<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2024.1395786</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Lactate and lactylation in macrophage metabolic reprogramming: current progress and outstanding issues</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Xu</surname><given-names>Bangjun</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2722373"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname><given-names>Yi</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2594130"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname><given-names>Ning</given-names>
</name>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/657033"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Geng</surname><given-names>Qing</given-names>
</name>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1016438"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><institution>Department of Thoracic Surgery, Renmin Hospital of Wuhan University</institution>, <addr-line>Wuhan</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Yi Wu, Xi&#x2019;an Jiaotong University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Edward Sherwood, Vanderbilt University Medical Center, United States</p>
<p>Jonas Aakre Wik, University of Oslo, Norway</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Ning Li, <email xlink:href="mailto:md.lining@whu.edu.cn">md.lining@whu.edu.cn</email>; Qing Geng, <email xlink:href="mailto:gengqingwhu@whu.edu.cn">gengqingwhu@whu.edu.cn</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>05</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1395786</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Xu, Liu, Li and Geng</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Xu, Liu, Li and Geng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>It is commonly known that different macrophage phenotypes play specific roles in different pathophysiological processes. In recent years, many studies have linked the phenotypes of macrophages to their characteristics in different metabolic pathways, suggesting that macrophages can perform different functions through metabolic reprogramming. It is now gradually recognized that lactate, previously overlooked as a byproduct of glycolytic metabolism, acts as a signaling molecule in regulating multiple biological processes, including immunological responses and metabolism. Recently, lactate has been found to mediate epigenetic changes in macrophages through a newfound lactylation modification, thereby regulating their phenotypic transformation. This novel finding highlights the significant role of lactate metabolism in macrophage function. In this review, we summarize the features of relevant metabolic reprogramming in macrophages and the role of lactate metabolism therein. We also review the progress of research on the regulation of macrophage metabolic reprogramming by lactylation through epigenetic mechanisms.</p>
</abstract>
<kwd-group>
<kwd>lactate</kwd>
<kwd>lactylation</kwd>
<kwd>Post-translational modification (PTM)</kwd>
<kwd>macrophage</kwd>
<kwd>metabolic reprogramming</kwd>
</kwd-group>
<contract-num rid="cn001">82102269</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<counts>
<fig-count count="3"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="123"/>
<page-count count="13"/>
<word-count count="6842"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Innate Immunity</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Traditionally, both tissue-resident and recruited macrophages polarize into two simplified distinct phenotypes stimulated by microenvironmental factors in pathological conditions: the classically activated phenotype (M1) and the alternatively activated phenotype (M2) (<xref ref-type="bibr" rid="B1">1</xref>). M1 macrophages, which are typically activated by lipopolysaccharide (LPS) or Th1 cytokines (e.g., IFN-&#x3b3;, GM-CSF), are pro-inflammatory and produce high levels of pro-inflammatory cytokines (<xref ref-type="bibr" rid="B2">2</xref>). In contrast, M2-type macrophages can be polarized by Th2 cytokines (e.g., IL-4, IL-13, IL-10) to possess anti-inflammatory properties. IL-4 and IL-13 activate STAT6 via IL-4R&#x3b1;, whereas IL-10 activates STAT3 via IL-10R, leading to the polarization of M2 macrophages (<xref ref-type="bibr" rid="B3">3</xref>). M2 macrophages exhibit anti-inflammatory effects through the expression of various anti-inflammatory molecules and endocytosis receptors, such as scavenger receptors (<xref ref-type="bibr" rid="B4">4</xref>). Besides, M2 macrophages generate profibrotic and pro-repair factors like PDGF, VEGF, THBS1, and TGF-&#x3b2;1. They also play a role in inducing the epithelial-mesenchymal transition (EMT) in alveolar epithelial cells, as well as the fibroblast-to-myofibroblast transition (FMT), contributing to fibrosis and tissue repair (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). Beyond the traditional M1 and M2 macrophage phenotypes, macrophages recruited into the tumor microenvironment (TME) during tumorigenesis and progression are referred to as tumor-associated macrophages (TAM). In the early stages of tumorigenesis, TAM typically exhibits an immune-promoting phenotype with pro-inflammatory and anti-tumor effects, resembling the M1 phenotype (<xref ref-type="bibr" rid="B7">7</xref>). However, as tumors progress, factors like an acidic environment and hypoxia in the TME can induce a metabolic reprogramming of TAM towards an immunosuppressive phenotype akin to the M2 phenotype. This shift promotes tumor growth, angiogenesis, and metastasis, which is correlated with a poorer prognosis (<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>In macrophages, metabolic reprogramming refers to adaptive changes in the cell&#x2019;s energy metabolism during its differentiation and activation (<xref ref-type="bibr" rid="B11">11</xref>). Macrophages with different phenotypes have some degree of metabolic heterogeneity in pathways such as glycolysis, the pentose phosphate pathway (PPP), oxidative phosphorylation (OXPHOS), the tricarboxylic acid cycle (TCA cycle), fatty acid synthesis (FAS), arginine metabolism, and glutamine metabolism. This heterogeneity of metabolic profiles correlates with the heterogeneity of macrophage phenotypes (<xref ref-type="bibr" rid="B12">12</xref>). Macrophages display plasticity in both their metabolic and functional characteristics, with their metabolic processes being modulated by the surrounding microenvironment, subsequently influencing their activation and polarization states (<xref ref-type="bibr" rid="B13">13</xref>). This phenotypic plasticity is emerging as a novel therapeutic tool for the treatment of tumors and chronic inflammatory diseases such as atherosclerosis and rheumatoid arthritis, by regulating macrophage signaling and metabolic pathways as well as reprogramming the macrophage phenotype (<xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>). However, different phenotypes of macrophages have varying degrees of plasticity. M2 macrophages are highly plastic, enabling them to easily repolarize to the M1 phenotype. Meanwhile, M1 macrophages are unable to repolarize to&#xa0;the M2 phenotype due to the damaging effect of NO produced by&#xa0;arginine metabolism on the mitochondrial oxidative phosphorylation process. Consequently, the plasticity of macrophage phenotypes is intricately linked to their metabolic features (<xref ref-type="bibr" rid="B18">18</xref>).</p>
<p>Lactate is the end product of glycolysis, and it has long been recognized as a waste product of metabolism (<xref ref-type="bibr" rid="B19">19</xref>). However, evidence is now mounting that lactate has multiple biological functions. Lactate can act as a signaling molecule to regulate various processes such as metabolism, immune response, and intercellular communication (<xref ref-type="bibr" rid="B20">20</xref>). Lactylation is a novel histone post-translational modification first discovered and proposed by Zhang D et&#xa0;al. in 2019. In macrophages, Zhang D et&#xa0;al. found that the intracellular lactate accumulated both endogenously via the glycolytic pathway and exogenously by taking up from the extracellular milieu, can lactylate histone lysine through an endogenous &#x201c;lactate clock&#x201d; mechanism, which regulates the transcriptional expression of related genes that transform macrophage phenotypes (<xref ref-type="bibr" rid="B21">21</xref>). As a newly discovered post-translational modification, lactylation has been found in both histones and non-histone proteins. Histone modifications can regulate gene transcription and expression by altering chromatin structure, while non-histone modifications on proteins including transcription factors and metabolic enzymes can regulate their functions, such as protein stability, activity, interactions, and localization (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). It has been known that covalent histone modifications like acetylation and methylation can achieve chromatin remodeling by affecting histone-DNA, histone-histone, and histone-chaperone interactions (<xref ref-type="bibr" rid="B24">24</xref>). Alterations in the relaxed/condensed state of chromatin can affect the binding of transcription factors to promoters, thereby affecting gene transcription and expression (<xref ref-type="bibr" rid="B25">25</xref>). In Zhang D et&#xa0;al.&#x2019;s study, the ChIP-seq data showed that both lactylation and acetylation at the histone H3K18 site were enriched in the promoter region. In addition, they demonstrated that the H3K18la modification at the promoter during M1 polarization can directly promote the transcription of homeostatic genes (<xref ref-type="bibr" rid="B21">21</xref>). Nonetheless, further evidence is needed to support the molecular mechanism through which lactylation regulates the transcription of target genes.</p>
<p>There are two different isomers of lactate: L-lactate and D-lactate. These correspond to two lactylation pathways, L-lactylation (direct lactylation) and D-lactylation (indirect lactylation). L-lactate and its lactylation modification process are primarily utilized to regulate physiological and pathological processes such as signal transduction (<xref ref-type="bibr" rid="B26">26</xref>). Therefore, unless otherwise specified, &#x201c;lactate&#x201d; herein generally refers to L-lactate. D-lactate is mainly produced from methylglyoxal (MGO), a byproduct of glycolysis, via the glyoxalase pathway (<xref ref-type="bibr" rid="B27">27</xref>). In 2020, Gaffney DO et&#xa0;al. found that lactoylglutathione (LGSH), which is not able to produce D-lactate in the absence of glyoxalase 2 (GLO2), indirectly modifies non-histone proteins, such as glycolytic metabolic enzymes, through non-enzymatic lysine lactylation, thereby regulating metabolic pathways such as glycolysis through negative feedback mechanism (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B28">28</xref>). D-lactate can also act as a signaling molecule in the regulation of macrophage polarization, but the direction of macrophage polarization depends on the signaling pathways regulated by L-lactate (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>). Studies also demonstrated that HDAC1&#x2013;3 serve as major cellular delactylases, which reversibly and dynamically regulate histone lactylation. In addition, the delactylase activities of HDAC1 and HDAC3 are site-specific (<xref ref-type="bibr" rid="B26">26</xref>).</p>
<p>In short, there is increasing evidence that lactate, an important metabolite of macrophages, can play a role in the metabolic reprogramming process of macrophages through lactylation modification to regulate macrophage phenotypes and help them adapt to different pathophysiological environments. In this review,&#xa0;we summarize the characteristics of relevant metabolic reprogramming in macrophages as well as the role of lactate metabolism therein. Furthermore, we discuss the molecular mechanisms by which lactylation regulates macrophage metabolic reprogramming as well as the role of lactylation in the different pathophysiological processes in which macrophages are involved.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Relevant metabolic reprogramming of macrophage</title>
<sec id="s2_1">
<label>2.1</label>
<title>Glycolysis and oxidative phosphorylation</title>
<p>Glycolysis is commonly recognized as an important metabolic pathway for cells to produce lactate and energy from glucose under hypoxic conditions, but pro-inflammatory macrophages and tumor cells prefer to rely on glycolysis in normoxia (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Despite being less efficient than OXPHOS in terms of the amount of ATP yielded, producing only 2 molecules of ATP per glucose molecule, glycolysis excels in producing ATP rapidly (<xref ref-type="bibr" rid="B32">32</xref>). Generally speaking, macrophage polarization to M1/M2 phenotype requires glucose metabolic reprogramming: M1 macrophages exhibit enhanced aerobic glycolysis and diminished OXPHOS to meet short-term energy demands of acute inflammation at the early stage of an infection, while M2 macrophages display enhanced mitochondrial OXPHOS (<xref ref-type="bibr" rid="B33">33</xref>&#x2013;<xref ref-type="bibr" rid="B35">35</xref>). Studies have demonstrated that inhibiting glycolytic processes prevents macrophage polarization to the M1 phenotype, leading to the attenuation of LPS-induced inflammatory responses and reduced acute lung injury (ALI) in mice (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>). Hypoxia-inducible factor-1&#x3b1; (HIF-1&#x3b1;) contributes to the regulation of glycolysis as well as the induction of pro-inflammatory gene expression, and it plays a crucial role in macrophage activation and polarization to the M1 phenotype (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>). Moreover, Pyruvate Kinase M2 (PKM2), a key enzyme promoting the Warburg effect, serves as an important regulator of macrophage polarization, glycolytic metabolic reprogramming, and IL-1&#x3b2; production (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B40">40</xref>). The HIF-1&#x3b1;/PKM2 axis plays a crucial role in driving the M1 phenotype transformation and pro-inflammatory activities, regulating target genes like glucose transporter protein 1 (GLUT1), glycolytic enzymes such as lactate dehydrogenase A (LDHA) and pyruvate dehydrogenase kinase 1 (PDK1), as well as pro-inflammatory factors such as IL-1&#x3b2; (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Meanwhile, PKM2 also promotes the secretion of HMGB1 protein, which mediates inflammatory responses in activated macrophages (<xref ref-type="bibr" rid="B42">42</xref>). Activation of PKM2 through DASA-58 and TEPP-46 leads to PKM2 activation via tetramer formation, suppressing the Warburg effect and lactate production without nuclear translocation. The above phenomenon is known as &#x201c;the PKM2 paradox in the Warburg effect&#x201d;. This process resulted in the downregulation of M1 phenotypic gene expression in macrophages regulated by the HIF-1&#x3b1;-PKM2 interaction, attenuating the LPS-induced M1 macrophage phenotype and promoting a shift towards typical M2 features (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B43">43</xref>). In conclusion, the Warburg effect is critical for the polarization and maintenance of the M1 macrophage phenotype (<xref ref-type="bibr" rid="B44">44</xref>).</p>
<p>During glycolytic metabolism in macrophages, a series of glycolytic enzymes play crucial roles in regulating metabolic reprogramming (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1</bold></xref>). The first enzyme that limits the rate of glycolysis is hexokinase (HK), which catalyzes the transformation of glucose into glucose-6-phosphate (G-6-P). In sepsis, Yuan Y et&#xa0;al. showed that the transcription factor KLF14 suppresses immune function by inhibiting the transcription of HK2, decreasing glycolysis, and causing M1-type macrophages to secrete inflammatory factors less (<xref ref-type="bibr" rid="B45">45</xref>). In their study on autoimmune thyroid disease, Cai T et&#xa0;al. found that HK3 knockdown or knockout reduced the proportion of M1 macrophages in both <italic>in vitro</italic> and <italic>in vivo</italic> experiments, supporting the idea that HK3 induces macrophage polarization toward the M1 phenotype through metabolic reprogramming (<xref ref-type="bibr" rid="B46">46</xref>). The key rate-limiting step in glycolysis is the transformation of F-6-P to F-1,6-BP, which is catalyzed by phosphofructokinase 1 (PFK1). Fructose-6-phosphate-2-kinase/fructose-2,6-bisphosphatase (PFKFB) catalyzes the transformation of F-6-P to F-2,6-BP, which is the strongest activator of PFK1 (<xref ref-type="bibr" rid="B47">47</xref>). Schilperoort M et&#xa0;al. found that the PFKFB2-mediated glycolytic pathway is rapidly activated in macrophages after phagocytosis and that the lactate it produces promotes the expression of the efferocytosis receptors MerTK and LRP1 via calcium signaling, thereby driving sustained phagocytosis (<xref ref-type="bibr" rid="B48">48</xref>). Mager CE et&#xa0;al. found that MKP-1 defects mediate increased PFKFB3 expression via the p38 MAPK pathway in both an E. coli-infected mouse model of sepsis and an LPS-stimulated macrophage model, leading to upregulation of macrophage glycolysis and the development of sepsis (<xref ref-type="bibr" rid="B49">49</xref>). The rate-limiting enzyme of glycolysis, pyruvate kinase (PK), catalyzes the conversion of phosphoenolpyruvate (PEP) to pyruvate. Its isoform, PKM2, is a&#xa0;crucial enzyme that stimulates the inflammatory response and Warburg effect in macrophages (<xref ref-type="bibr" rid="B42">42</xref>). PDK1, an important regulator of glucose metabolism, inactivates pyruvate dehydrogenase (PDH) by phosphorylation, thereby preventing the production of acetyl-CoA from pyruvate and facilitating lactate production via the glycolytic pathway (<xref ref-type="bibr" rid="B12">12</xref>). In a study on atherosclerosis, Forteza MJ et&#xa0;al. found that the promotion of vascular inflammation by the PDK/PDH axis was associated with M1 macrophage polarization (<xref ref-type="bibr" rid="B50">50</xref>). Furthermore, Semba H et&#xa0;al. found that PDK1 promotes both M1 macrophage polarization and macrophage migration under mild hypoxia by inducing glycolysis via the HIF-1&#x3b1;-PDK1 axis (<xref ref-type="bibr" rid="B51">51</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Relevant enzymes in macrophage glycolysis and their regulatory mechanisms (Created with <uri xlink:href="https://BioRender.com">BioRender.com</uri>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1395786-g001.tif"/>
</fig>
<p>There is ongoing debate concerning the function of glycolysis in M2 macrophages. It was previously believed that M2 macrophages had lower glycolysis levels compared to M1 macrophages since they primarily relied on OXPHOS for glucose metabolism (<xref ref-type="bibr" rid="B52">52</xref>). However, recent studies have revealed a potentially significant role of glycolysis in M2 macrophage activation through the use of 2-DG, a glycolysis inhibitor. Several studies have found that 2-DG inhibits glycolysis and OXPHOS, impacting M2 macrophage activation (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B53">53</xref>). A study by Covarrubias AJ et&#xa0;al. discovered an increase in glucose uptake in IL-4-treated BMDM, which correlated with an AKT-dependent rise in glycolysis and oxidative metabolism. The researchers found that similar to the &#x3b2;-oxidation inhibitor Etomoxir, 2-DG reduced the expression of certain M2 genes induced by IL-4 (e.g., Arg1, Retnla, Mgl2), suggesting that glycolysis is required for M2 macrophage activation. However, their study also revealed that IL-4 activates ATP citrate lyase (Acly) in a phosphorylated manner via the AKT-mTORC1 pathway, independently of the classical JAK-STAT6 pathway. Acly is a key enzyme for acetyl CoA synthesis, and its expression can be induced by increasing histone acetylation of the aforementioned M2 genes (also known as AKT-dependent M2 genes). These findings imply that glycolysis is not the only pathway for M2 macrophage activation (<xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B55">55</xref>). Subsequently, Huang SC et&#xa0;al. demonstrated that IL-4 enhanced glycolysis in BMDM by increasing IRF4 expression through the mTORC2 pathway, thereby activating M2 macrophages. In their research, they found that 2-DG significantly inhibited the expression of M2-type activation markers such as RELM-&#x3b1; and PD-L2, and led to a decrease in the glycolytic indicators like extracellular acidification rate (ECAR) and glycolytic reserve (GR) (<xref ref-type="bibr" rid="B56">56</xref>). However, Wang F et&#xa0;al. showed that the 2-DG used to block glycolysis in the aforementioned study had a possible off-target effect: higher doses of 2-DG not only inhibited glycolysis and OXPHOS but also suppressed M2-type polarization of macrophages by reducing intracellular ATP concentration as well as down-regulating JAK-STAT6 signaling. It was found that the activation and polarization of M2 macrophages through the JAK-STAT6 pathway required a threshold level of intracellular ATP, which could be achieved by accumulating via the glycolysis/OXPHOS pathway. Therefore, glycolysis was not necessary for the activation of M2 macrophages when OXPHOS functioned normally. In their study, they treated IL-4-stimulated BMDM by glucose consumption or by using galactose instead of glucose and examined the expression of M2-type activation markers. The results showed that glycolytic inhibition did not affect BMDM activation when OXPHOS hadn&#x2019;t been damaged in BMDM (<xref ref-type="bibr" rid="B57">57</xref>). In conclusion, the specific role of glycolysis in activating M2 macrophages requires further investigation.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Arginine metabolism</title>
<p>Arginine undergoes complex metabolism in the body, serving as&#xa0;a precursor for various important biological compounds including nitric oxide (NO), citrulline, ornithine, urea, proline, glutamate, creatine, and polyamines (<xref ref-type="bibr" rid="B58">58</xref>). Different phenotypes of macrophages are characterized by distinct arginine metabolism. M1 macrophages express iNOS, which converts arginine to NO and citrulline. NO, along with its reactive nitrogen species derivatives, play diverse roles in macrophages: (1) They enable macrophages to exert proinflammatory, antibacterial, and cytotoxic effects (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>); (2) They inactivate iron-sulfur-containing complexes (mainly complexes I and II) in the mitochondrial electron transport chain (ETC), attenuates OXPHOS and prevents repolarization of M1-type macrophages to M2-type (<xref ref-type="bibr" rid="B18">18</xref>); (3) NO can participate in the metabolic reprogramming of the macrophage TCA cycle: NO&#x2019;s suppression of ACO2 leads to TCA cycle disruption. Additionally, NO can inhibit PDH and diminish its carbon flux in ways that are independent of the HIF-1-PDK1-PDH axis. Since glutaminolysis is a major anaplerotic pathway in macrophages, the above effects lead to increased uptake and utilization of glutamine by macrophages to compensate for the inhibitory effects of NO on ACO2 and PDH (<xref ref-type="bibr" rid="B61">61</xref>, <xref ref-type="bibr" rid="B62">62</xref>); (4) NO biphasically regulates iNOS expression in LPS-stimulated mouse macrophages via NF-&#x3ba;B. That effect depends on the local concentration of NO and up-/down-regulates the expression of pro-inflammatory proteins in the body, including iNOS and IL-6 (<xref ref-type="bibr" rid="B63">63</xref>). M2 macrophages express Arg1, which catabolizes arginine into ornithine and urea, in contrast to M1 macrophages. Ornithine can be catalyzed by ornithine decarboxylase (ODC) to synthesize polyamines and by ornithine aminotransferase (OAT) to synthesize proline (<xref ref-type="bibr" rid="B58">58</xref>). Meanwhile, the regulation of humoral immunity, the antiparasitic response, the allergic response, fibrosis, and wound healing is mediated by Arg1 and its catalytic downstream products (<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B64">64</xref>). Due to the pro-inflammatory and cytotoxic nature of NO, iNOS competes with Arg1 for the catabolic pathway of arginine to balance immune function and its damaging effects (<xref ref-type="bibr" rid="B60">60</xref>). Various pathogens, including Leishmania, Schistosoma mansoni, Toxoplasma gondii, and Mycobacterium TB, can compete with iNOS for the catabolization of arginine by upregulating the expression of Arg1, thereby reducing NO production to facilitate infections (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B65">65</xref>&#x2013;<xref ref-type="bibr" rid="B67">67</xref>).</p>
<p>Since macrophages have dichotomies similar to the iNOS/Arg1 dichotomy in arginine metabolism in many of the major metabolic pathways, the classification of M1/M2 phenotypes has been widely used in the literature as a classic and simple dichotomy. However, the phenotypic classification of different activated macrophages based solely on traits related to arginine metabolism is an oversimplified way of typing. The boundaries of the phenotypic classification of macrophages in question are not yet completely clear, and the distinction of biological behaviors of macrophages that have different phenotypes remains to be investigated (<xref ref-type="bibr" rid="B60">60</xref>).</p>
</sec>
</sec>
<sec id="s3">
<label>3</label>
<title>The linkage between lactate metabolism and macrophage metabolic reprogramming</title>
<p>The Warburg effect is present in a variety of cells, including M1 macrophages and tumor cells, which metabolize glucose to lactate under aerobic conditions. There are several features of the Warburg effect: (1) Aerobic glycolysis rapidly synthesizes ATP in the cytoplasm to meet short-term energy demands; (2) Intermediate products of aerobic glycolysis facilitate the biosynthesis of nucleotides, amino acids, and lipids; (3) Reduced production of reactive oxygen species (ROS) from mitochondrial OXPHOS lessens the harm that oxidative stress causes (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B69">69</xref>). Thus, to fit their survival milieu, M1 macrophages and tumor cells exhibit the Warburg effect as a result of metabolic reprogramming.</p>
<p>To perform its roles as a major energy source for mitochondrial respiration, a key glycolytic precursor, and a signaling molecule, lactate shuttles between cells and between compartments within the cell. This process connects the aerobic and glycolytic metabolic pathways. Cell-cell lactate shuttles are ubiquitous across various cells, tissues, and organs in the body, while intracellular lactate shuttles include cytoplasmic-mitochondrial exchange and cytoplasmic-peroxisomal exchange (<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B71">71</xref>). Mediated by transport proteins and receptors, the lactate shuttle involves several monocarboxylate transporters (MCTs), the two most extensively researched of which are MCT1 and MCT4: MCT1 is widely expressed in tissues and is involved in lactate uptake, while MCT4 is predominantly expressed in tissues with high glycolysis and is involved in lactate efflux (<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B73">73</xref>). However, the direction of lactate transport by MCTs <italic>in vivo</italic> depends on the lactate and proton concentration gradients (<xref ref-type="bibr" rid="B74">74</xref>).</p>
<p>Previous studies have shown that lactate, as a core molecule, plays a crucial role in regulating macrophage metabolic reprogramming. It has been found to inhibit the activation of M1 pro-inflammatory macrophages while promoting the polarization of M2 macrophages towards an anti-inflammatory and pro-angiogenic phenotype. These effects are mediated through various mechanisms, such as post-translational modification of histones and modulation of signaling pathways (<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B76">76</xref>): (1) Lactate is metabolized to pyruvate via LDH1, which stabilizes HIF-1&#x3b1; via inhibition of prolyl hydroxylase. HIF-1&#x3b1; promotes the expression of Arg-1 and VEGF in TAM in an IL-4/IL-13-independent manner, thereby inducing TAM to an M2-like phenotype. However, HIF-1&#x3b1; does not induce Arg-1 or VEGF during macrophage M1 polarization because HIF-1&#x3b1; protein expression is induced early and HIF-1&#x3b1; binds to the promoters of glycolytic genes, not Arg-1 or VEGF (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B76">76</xref>&#x2013;<xref ref-type="bibr" rid="B78">78</xref>) (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2A</bold></xref>). (2) Proton-sensing G protein-coupled receptors GPR132 and GPR65, which are highly expressed on the surface of macrophages, are activated by acidic TME from extracellular lactate. This activation triggers an intracellular signaling cascade that induces the expression of anti-inflammatory and pro-angiogenic genes in macrophages via the cAMP-ICER pathway, thereby promoting macrophage polarization to the M2 phenotype (<xref ref-type="bibr" rid="B79">79</xref>&#x2013;<xref ref-type="bibr" rid="B83">83</xref>) (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2B</bold></xref>). (3) Lactate negatively regulates TFEB through activation of mTORC1, which in turn decreases lysosomal degradation of HIF-2&#x3b1; by down-regulating macrophage ATP6V0d2 expression, thereby increasing macrophage anti-inflammatory and pro-angiogenic gene expression (<xref ref-type="bibr" rid="B84">84</xref>) (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2C</bold></xref>). (4) Lactate promotes tumor invasion by activating the mTORC2-AKT signaling pathway and promoting TAM polarization towards the M2 phenotype (<xref ref-type="bibr" rid="B85">85</xref>) (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2D</bold></xref>). (5) Lactate increases phosphorylation activation of the ERK/STAT3 pathway in macrophages and promotes macrophage M2 phenotype polarization, exerting anti-inflammatory and pro-angiogenic effects (<xref ref-type="bibr" rid="B86">86</xref>) (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2E</bold></xref>). (6) Macrophage G protein-coupled receptor GPR81 (HCAR1) is activated by physiological concentrations of lactate to downregulate the cAMP-PKA signaling pathway, which can mediate immunosuppression, promote angiogenesis, and other processes in tumor tissues (<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>) (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2F</bold></xref>). In addition, GPR81 is predominantly located in cell membranes but has also been identified in organelles, indicating its involvement in lactate transport between cell membranes and intracellular compartments (<xref ref-type="bibr" rid="B87">87</xref>). In a study concerning the mechanisms regulating the immunosuppressive macrophage phenotype in the pre-metastatic niche, Morrissey SM et&#xa0;al. found that lactate is involved in the regulation of the &#x201c;non-classical M1&#x201d; phenotype of macrophages. Tumor-derived exosomes (TDEs) activate two independent pathways that enhance glycolysis via the NF-&#x3ba;B pathway: (1) Activated HIF-1&#x3b1; upregulates GLUT-1 expression, which increases glucose uptake into the macrophage; (2) Activated NOS2 increases NO production, which diverts pyruvate to the lactate pathway by inhibiting OXPHOS. The aforementioned mechanisms cause macrophages to produce more lactate due to increased glycolysis, which can then stimulate PD-L1 expression by activating NF-&#x3ba;B, hence enhancing PD-L1-mediated immunosuppression (<xref ref-type="bibr" rid="B89">89</xref>). In contrast, Han S et&#xa0;al. found in a hepatocellular carcinoma model that D-lactate polarized M2 TAM to M1 phenotype and remodeled the immunosuppressive TME in hepatocellular carcinoma through inhibition of the PI3K-AKT pathway and activation of the NF-&#x3ba;B pathway (<xref ref-type="bibr" rid="B29">29</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Lactate&#x2019;s mechanisms in shaping tumor-associated macrophages into an M2-like phenotype. <bold>(A)</bold> Lactate promotes Arg-1 and VEGF expression through stabilization/activation of HIF-1&#x3b1;. <bold>(B)</bold> Proton-sensing GPR65/GPR132 activated by acidic TME from extracellular lactate induces M2-like gene expression via the cAMP-ICER pathway. <bold>(C)</bold> Lactate-activated mTORC1 negatively regulates TFEB, which reduces HIF-2&#x3b1; degradation by down-regulating ATP6V0D2 expression on the surface of the lysosome, thereby regulating immunosuppressive and pro-angiogenic M2-like gene expression. <bold>(D)</bold> Lactate-activated mTORC2-AKT pathway induces TAM to a pro-invasive M2-like phenotype. <bold>(E)</bold> Lactate activates the ERK-STAT3 pathway by phosphorylating ERK, which in turn induces anti-inflammatory and pro-angiogenic M2-like phenotypes. <bold>(F)</bold> GPR81/HCAR1 is activated by physiological concentrations of extracellular lactic acid, which induces PD-L1 expression via down-regulation of the cAMP-PKA pathway, thereby promoting tumor immune evasion. <bold>(G)</bold> Lactate promotes histone lactylation modification (yellow circle) at the promoter H3K18 site of Arg-1, VEGF and other M2-like genes in TAM to up-regulate their expression, thereby inducing an M2-like phenotype in TAM. (Created with <uri xlink:href="https://BioRender.com">BioRender.com</uri>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1395786-g002.tif"/>
</fig>
</sec>
<sec id="s4">
<label>4</label>
<title>Lactylation modifications are involved in regulating macrophage phenotype</title>
<p>Zhang D et&#xa0;al., 2019 discovered that M1 macrophages have an endogenous &#x201c;lactate clock&#x201d;, which regulates the transition of M1 macrophages to exhibit M2-type characteristics during the late stage of polarization through histone lactylation. They propose a regulatory mechanism whereby both endogenous lactate produced by aerobic glycolysis (Warburg effect) and exogenous lactate taken up by MCT in M1 macrophages can be enzymatically reacted to produce lactoyl coenzyme A, which adds a lactoyl moiety to the lysine tail of histones in a p53-dependent manner mediated by the acetyltransferase p300 (<xref ref-type="bibr" rid="B21">21</xref>). Although Patel R et&#xa0;al. predicted acetyl-CoA synthetase as a potential enzyme by using molecular docking and molecular dynamics (MD) simulations, there is still no direct evidence for the existence of lactyl-CoA synthetase or transferase that activates lactate to lactyl-CoA in mammals (<xref ref-type="bibr" rid="B90">90</xref>). This histone lactylation modification increases in a time-dependent manner and is predominantly present at the promoters of M2-type characteristic wound repair genes such as Arg-1. After 16&#x2013;24h, these H3K18la-modified M2 genes were activated for expression. M1 macrophages undergo an iNOS&#x2192;Arg1 expression switch, transitioning to the M2 phenotype to repair tissue damage caused by infection, etc. (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B91">91</xref>, <xref ref-type="bibr" rid="B92">92</xref>) (<xref ref-type="fig" rid="f3"><bold>Figures&#xa0;3D, E</bold></xref>). Subsequent studies have observed similar phenomena in pulmonary fibrosis, post-myocardial infarction repair, and intestinal inflammatory modulation (<xref ref-type="bibr" rid="B93">93</xref>&#x2013;<xref ref-type="bibr" rid="B95">95</xref>). In a subsequent research on TAM, Noe JT et&#xa0;al. proposed that early M1 macrophages with high glycolytic/low TCA activity could be modified by histone lactylation using lactate produced by glycolysis as the initiation of the M1&#x2192;M2 phenotypic transition. Later, with the decrease of glucose and increase of lactate in the microenvironment, M2 macrophages undergo metabolic reprogramming leading to high TCA activity. This process promotes M2-type gene expression, immunosuppression, and tumor progression by converting lactate to pyruvate for entering into the TCA cycle as well as producing acetyl-coA to promote histone acetylation-dependent gene expression (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B96">96</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Role of the Warburg effect as well as histone and non-histone lactylation mediated by lactate in the regulation of macrophage phenotype. <bold>(A)</bold> HIF-1&#x3b1; induced by activation of NF-&#x3ba;B signaling after exposure to pro-inflammatory stimuli such as LPS and hypoxia can undergo nuclear translocation and form a complex by interacting with HIF-1&#x3b2; and PKM2 dimer, which also undergo nuclear translocation. This complex induces the expression of M1-like genes by acting on the HRE at the promoters of the target genes, polarizing macrophages to the M1 phenotype. <bold>(B)</bold> Activation of M1 macrophages upregulates the expression of iNOS, which metabolizes arginine to NO. Accumulation of NO damages OXPHOS, leading to enhanced glycolysis in M1 macrophages. <bold>(C)</bold> LPS-recognized TLR activates PI3K-AKT via BCAP, which reduces inflammation by phosphorylating and inhibiting downstream molecules GSK3&#x3b2; and FOXO1, as well as enhances glycolysis to produce lactate. <bold>(D)</bold> Lactate (L-lactate) in the cytoplasm can be either endogenous lactate that accumulates via macrophage glycolysis production or exogenous lactate that is taken up from the extracellular environment via MCT1 at the plasma membrane. <bold>(E)</bold> Histone lactylation is shown by the blue arrow. Lactate in M1 macrophages can be catalyzed by currently unidentified enzymes to generate Lactyl-CoA, which initiates an endogenous &#x201c;lactate clock&#x201d; after entering the nucleus, and M2 signature genes modified by lactylation are activated for expression, resulting in cells exhibiting M2-like features. <bold>(F)</bold> The glycolytic byproduct MGO binds to glutathione via GLO1 to form LGSH. LGSH cannot produce D-lactate in the absence of GLO2, but rather indirectly modifies glycolytic enzymes through non-enzymatic lysine lactoylation, which negatively regulates glycolysis by inhibiting glycolytic enzymes (as shown by the red arrows). <bold>(G)</bold> The red arrows show the processes in which non-histone lactylation is involved in regulation. Lactate accumulation from M1 macrophage glycolysis can result in the lactylation of PKM2, which activates the PKM2 dimer to a tetrameric form and exerts an inhibitory effect on macrophage glycolysis. In addition, the stability of HIF-1&#x3b1; in M1 macrophages may also be regulated by lactylation modification. (Created with <uri xlink:href="https://BioRender.com">BioRender.com</uri>).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-15-1395786-g003.tif"/>
</fig>
<p>However, the above findings remain controversial. Further research by Dichtl S et&#xa0;al. showed that in LPS-activated macrophages, histone lactylation did not correlate with the activation of M2 macrophages or the expression of genes associated with M2 activation, such as Mrc1, Retnla, and PD-L2. LPS-induced upregulation of Arg-1 expression was dependent on the autocrine/paracrine IL-6 and its downstream activated STAT3 signaling, without involving histone lactylation upregulation. The primary cause of the intracellular accumulation of lactate and the upregulation of lactylation in M1 macrophages is the detrimental effect of NO generated by arginine metabolism on mitochondrial OXPHOS (<xref ref-type="bibr" rid="B97">97</xref>). This implies that histone lactylation may not be the exclusive regulatory pathway for genes involved in M2 activation. Furthermore, Van den Bossche J et&#xa0;al. have shown in a previous study that the impairing effect of NO on mitochondrial OXPHOS function inhibits the phenotypic repolarization process M1&#x2192;M2 (<xref ref-type="bibr" rid="B18">18</xref>) (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3B</bold></xref>). Therefore, there may be two mechanisms for the M1&#x2192;M2 phenotype transition described previously: (1) Induced by histone lactylation or other pathways, Arg-1 competes with iNOS for arginine catabolism, which reduces NO production and attenuates the degree of damage by OXPHOS, allowing M1 macrophages to repolarize to the M2 phenotype to a certain extent; (2) Lactate produced by M1 macrophages via glycolysis changes the extracellular microenvironment, prompting polarization of recruited circulating monocytes to the M2 phenotype. In sum, more research is needed to determine the precise function lactylation plays in the macrophage M1&#x2192;M2 phenotypic change.</p>
<p>As a newly identified toll-like receptor (TLR) signaling adapter, the function of the B-cell adapter for PI3K (BCAP) in controlling macrophage transformation into an M2 repair phenotype is confirmed by the study of Irizarry-Caro RA et&#xa0;al (<xref ref-type="bibr" rid="B98">98</xref>). In macrophages, recognition of LPS by TLR4 activates NF-&#x3ba;B, which ultimately generates pro-inflammatory factors and improves phagocytosis (<xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B100">100</xref>). TLR also activates PI3K-AKT via BCAP and activated AKT contributes to the transformation of macrophages into an anti-inflammatory repair phenotype via two pathways: (1) PI3K-AKT-GSK3&#x3b2;-FOXO1 pathway: phosphorylation of AKT inhibits FOXO1 and GSK3&#x3b2;, its downstream molecules, thus downregulating inflammation; (2) Aerobic glycolysis (the Warburg effect) and histone lactylation: AKT increases lactate production by enhancing aerobic glycolysis. Lactate accumulation causes histone lactylation, which upregulates the expression of wound repair genes (<xref ref-type="bibr" rid="B93">93</xref>) (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3C</bold></xref>). The significance of this study lies in: (1) suggesting that BCAP has a crucial switch-like role in promoting macrophages to switch to the M2 repair phenotype; (2) explaining a regulatory mechanism of the Warburg effect in macrophages at the molecular level; (3) providing a possible drug target for the treatment of diseases&#xa0;caused by over-activation of the macrophage pro-inflammatory phenotype.</p>
<p>Non-histone lactylation modification also plays an important role in regulating macrophage phenotype. In particular, non-histone lactylation has been shown to metabolically reprogram the immune phenotype of macrophages by modulating the activity of enzymes involved in aerobic glycolysis. Gaffney DO et&#xa0;al. discovered non-enzymatic lysine lactoylation, which negatively regulates glycolysis by modifying glycolytic enzymes, inhibiting enzyme activity, and reducing the level of glycolytic metabolites. LGSH mediates this lactoylation process, which is a D-lactylation (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>) (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3F</bold></xref>). Wang J et&#xa0;al. discovered that lactate accumulating from aerobic glycolysis in M1 macrophages leads to lactylation modification of PKM2 at K62, leading to PKM2 activation into its tetrameric form and reducing dimerization and nuclear translocation. This resulted in the suppression of the macrophage Warburg effect, decreased lactate production, and facilitated the transition of M1 macrophages to the M2 repair phenotype (<xref ref-type="bibr" rid="B101">101</xref>) (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3G</bold></xref>). The significance of this study lies in: (1) revealing a possible mechanism to regulate the inflammation/repair balance and the &#x201c;lactate clock&#x201d;: By limiting the rate of lactate production from macrophage aerobic glycolysis through negative feedback, it restricts the over-inflammation in M1 macrophages while delaying the activation of genes modified by histone lactylation to prevent inflammation from subsiding prematurely; (2) revealing that the PKM2 paradox in the Warburg effect exists not only during the pharmacological activation of PKM2, but also during the transition of macrophages from a pro-inflammatory to a reparative phenotype; (3) providing an explanation for why lactate failed to increase Arg-1 expression in M0 macrophages but did so in LPS-induced M1 macrophages in the Dichtl S et&#xa0;al. study: LPS stimulation upregulates PKM2 expression in macrophages, while lactate activates PKM2 through non-histone lactylation. Together, they work synergistically to inhibit glycolysis and increase Arg-1 expression. In addition, Yang K et&#xa0;al. found that exogenous lactate has deleterious effects on sepsis patients by mediating the lactylation and acetylation modifications of HMGB1 in macrophages, inducing the release of lactylated/acetylated HMGB1 from cells by exosomal secretion (<xref ref-type="bibr" rid="B102">102</xref>). As an important damage associated molecular pattern (DAMP) molecule, HMGB1 induces macrophage polarization toward the M1 phenotype while maintaining migratory capacity and some M2 characteristics (<xref ref-type="bibr" rid="B103">103</xref>). Subsequently, Du S et&#xa0;al. found a similar process in a hepatic ischemia-reperfusion injury model and found that heat shock protein A12A (HSPA12A) could exert its hepatoprotective effects by preventing M1 macrophage activation via inhibiting the lactylation and exosomal secretion of HMGB1 (<xref ref-type="bibr" rid="B104">104</xref>). HIF-1&#x3b1; can produce lactate by inducing aerobic glycolysis in macrophages in response to pro-inflammatory stimuli. Studies have demonstrated that the stability of HIF-1&#x3b1; can be regulated by a variety of post-translational modifications, such as acetylation, ubiquitination, and phosphorylation. Therefore, it is likely that a lactylation modification of HIF-1&#x3b1; occurs in response to pro-inflammatory stimuli. However, further research is still needed to determine whether lactylation exists in HIF-1&#x3b1; under pro-inflammatory stimuli, as well as the function of lactylation on HIF-1&#x3b1; and how it works (<xref ref-type="bibr" rid="B105">105</xref>, <xref ref-type="bibr" rid="B106">106</xref>) (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3G</bold></xref>).</p>
</sec>
<sec id="s5">
<label>5</label>
<title>Role of lactylation in pathophysiological processes associated with macrophage metabolic reprogramming</title>
<sec id="s5_1">
<label>5.1</label>
<title>Inflammation and repair</title>
<p>In macrophages, pro-inflammatory stimuli such as LPS and hypoxia enhance HIF-1&#x3b1; transcription by inducing the activation of&#xa0;NF-&#x3ba;B signaling. HIF-1&#x3b1; expression undergoes nuclear translocation and binds to HIF-1&#x3b2; to form a complex, which in turn binds to the hypoxia-responsive element (HRE) at the promoter of target genes. The inactive dimeric PKM2 also undergoes nuclear translocation and interacts with HIF-1&#x3b1;. They work together to regulate the expression of target genes, thereby inducing macrophage polarization to the M1 phenotype, which exerts pro-inflammatory effects in response to injurious stimuli and exacerbates the original inflammatory response (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B107">107</xref>&#x2013;<xref ref-type="bibr" rid="B109">109</xref>) (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3A</bold></xref>). In summary, M1 macrophages can increase aerobic glycolysis through at least the following mechanisms: (1) The NO generated during the arginine degradation by iNOS can impair mitochondrial OXPHOS, leading to an increase in macrophage aerobic glycolysis (<xref ref-type="bibr" rid="B18">18</xref>); (2) TLR can activate PI3K-AKT via BCAP, thereby enhancing aerobic glycolysis (<xref ref-type="bibr" rid="B99">99</xref>); (3) The mitochondrial network of M1 macrophages gradually breaks from elongated to fragmented after LPS stimulation. The expression and activity of PDH in the broken mitochondria are down-regulated, leading to inhibition of the pathway for the production of acetyl-CoA from pyruvate, thereby enhancing aerobic glycolysis (<xref ref-type="bibr" rid="B110">110</xref>). The accumulation of lactate produced by aerobic glycolysis in M1 macrophages triggers the endogenous &#x201c;lactate clock&#x201d; mechanism. This results in the delayed activation of the M2 characteristic genes such as Arg-1 and the M2 core transcription factor STAT6, both of which are regulated by H3K18 histone lactylation. Eventually, the M2 anti-inflammatory phenotype manifests in macrophages (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B111">111</xref>). In addition, as mentioned previously, lactate accumulated in macrophages can exert an inhibitory effect on aerobic glycolysis through non-histone lactylation modifications: (1) Non-enzymatic lysine lactoylation of glycolytic enzymes can limit aerobic glycolysis by inhibiting enzyme activity (<xref ref-type="bibr" rid="B28">28</xref>); (2) Lactylation of PKM2 can both increase its activity and inhibit its nuclear translocation, thus reducing aerobic glycolysis (<xref ref-type="bibr" rid="B101">101</xref>). Therefore, lactylation may modulate the inflammatory injury/anti-inflammatory repair balance in tissues by affecting the metabolic reprogramming process in macrophages.</p>
<p>Additional research has demonstrated that H4K12 lactylation can mediate cellular inflammation in addition to H3K18la. Pan RY et&#xa0;al. found that H4K12la modification activated the transcription of LDHA, PKM2, and HIF-1&#x3b1;, thereby exacerbating the pro-inflammatory activation and dysfunction of microglia in Alzheimer&#x2019;s disease through a positive feedback loop of glycolysis-H4K12la-PKM2 (<xref ref-type="bibr" rid="B112">112</xref>). Subsequently, in a study on the pathogenesis of diabetic cardiomyopathy, Ma XM et&#xa0;al. found that although lactate can induce both H3K18la and H4K12la in macrophages, it mainly mediated macrophage inflammatory responses and induced the expression of HIF-1&#x3b1; and inflammatory cytokines like IL-1&#x3b2; via H4K12la in a high-free fatty acid environment (<xref ref-type="bibr" rid="B113">113</xref>). The above studies suggest that different extracellular microenvironments may lead to histone lactylation at different sites, which in turn may exhibit different regulatory effects.</p>
</sec>
<sec id="s5_2">
<label>5.2</label>
<title>Fibrillation</title>
<p>Abnormal repair of tissues after inflammation can lead to the onset of fibrosis. Macrophages can be polarized to a pro-fibrotic phenotype in addition to an anti-inflammatory repair phenotype to modulate tissue fibrosis (<xref ref-type="bibr" rid="B114">114</xref>). In idiopathic pulmonary fibrosis (IPF), the pro-fibrotic phenotype of macrophages can be regulated by local&#xa0;tissue through histone lactylation. Cui H et&#xa0;al. demonstrated that myofibroblasts undergoing aerobic glycolysis secrete lactate into the extracellular environment, where myofibroblasts, alveolar macrophages, and lactate form fibrotic niches. Exogenous lactate can upregulate the expression of pro-fibrotic genes like Arg-1, PDGFA, THBS1, and VEGFA in alveolar macrophages through histone lactylation at the promoter, leading to the pro-fibrotic phenotype and accelerating the progression of pulmonary fibrosis (<xref ref-type="bibr" rid="B94">94</xref>, <xref ref-type="bibr" rid="B115">115</xref>, <xref ref-type="bibr" rid="B116">116</xref>). However, their research still has some limitations: (1) There isn&#x2019;t any concrete proof that lactate-induced alterations in macrophage phenotype are involved in the regulation of pulmonary fibrosis; (2) It is yet unclear what functions histone lactylation serves in other cells throughout the fibrosis process, such as mesenchymal stem cells and alveolar epithelial cells.</p>
</sec>
<sec id="s5_3">
<label>5.3</label>
<title>Tumor</title>
<p>Previous research has demonstrated that tumor cells can shape TAM into an M2 immunosuppressive phenotype, where lactate is a key signaling molecule that controls macrophage metabolic reprogramming, hence suppressing immune function and promoting tumor growth. Lactate produced by tumor cells through glycolysis creates a lactate-enriched TME, which can affect macrophages recruited into the TME by different means such as being recognized by and binding to GPR132. Lactate can stabilize HIF-1&#x3b1; and induce the expression of M2 genes such as Arg-1, Fizz-1, Mgl-1, VEGF, and PPAR-&#x3b3;, thereby inducing TAM polarize to an M2 immunosuppressive phenotype and promoting tumor growth, metastasis, and invasion (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B117">117</xref>) (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref>).</p>
<p>Recently discovered lactylation has provided hints on the molecular mechanism of the above regulatory roles of lactate. The study by Fang X et&#xa0;al. reached several conclusions: (1) Due to the presence of excess lactate in TME and the limited availability of glucose for macrophages, endogenous lactate produced by macrophage glycolysis is a non-essential factor in TAM polarization and tumor progression, instead, exogenous lactate produced by tumor cells is a key factor; (2) Exogenous lactate is transported into TAM via MCT1, which stabilizes HIF-1&#x3b1; and upregulates its expression by promoting histone lactylation at the H3K18 site of the promoter of M2 genes, such as Arg-1 and VEGF, in TAM, thereby inducing the polarization of TAM to an M2 phenotype; (3) The induction of macrophage polarization to an M2 phenotype by lactate and IL-4 is independent of the MPC-mediated metabolic pathway of mitochondrial respiration (<xref ref-type="bibr" rid="B118">118</xref>) (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2G</bold></xref>). Some literature has reported on the role of lactylation in immunosuppression and its contribution to tumor progression in various cancer diseases. Wang L et&#xa0;al. found that upregulating PCSK9 expression in a colon cancer model led to increased lactylation of macrophage proteins and a shift of TAM towards the M2 phenotype, suggesting a correlation between the two (<xref ref-type="bibr" rid="B119">119</xref>). Yang H et&#xa0;al. evaluated the lactylation levels of relevant prognostic genes in a gastric cancer model. Their findings showed that patients with high lactylation levels were associated with greater immune escape potential and lower immunotherapy response rates (<xref ref-type="bibr" rid="B120">120</xref>). Chaudagar K et&#xa0;al. identified that lactylation promotes TAM immunosuppressive phenotypic polarization and exerts pro-tumorigenic effects in a PTEN/p53-deficient prostate cancer model. They are also focusing on relevant anti-tumor therapies targeting the signaling pathways that inhibit the production of lactate by tumor cells (<xref ref-type="bibr" rid="B121">121</xref>, <xref ref-type="bibr" rid="B122">122</xref>).</p>
<p>Research on the molecular mechanism of lactylation in promoting tumor progression and the development of anti-tumor targeting drugs based on it are still in progress. Therapies targeting the metabolic pathway and signaling pathway of lactate production, as well as the transport and recognition of lactate between tumor cells and macrophages, is a relatively novel research field in anti-tumor therapy research (<xref ref-type="bibr" rid="B123">123</xref>).</p>
</sec>
</sec>
<sec id="s6">
<label>6</label>
<title>Concluding remarks</title>
<p>The metabolic reprogramming that occurs in macrophages during various pathophysiological processes in which they are involved has been extensively studied, yet there are still several questions at the molecular mechanism level that remain to be addressed. Lactylation is a newfound post-translational modification of proteins initially observed in macrophages. Its characteristic as mediated by the glycolytic product lactate suggests a novel connection between macrophage metabolic features and phenotypic transformation. This review summarizes the features of macrophage-associated metabolic reprogramming and the role of lactate metabolism therein. In addition, it discusses the molecular mechanisms identified so far for the regulation of macrophage metabolic reprogramming by lactylation modifications and their regulatory roles in related pathophysiological processes.</p>
<p>Although the mechanism by which lactylation regulates metabolic reprogramming in macrophages has been clinically translated and has yielded some results, there are still some issues that remain to be investigated at the molecular level: (1) The threshold lactate concentration for inducing lactylation as well as its specificity at tissue, cellular, and protein levels; (2) The mechanism by which the lactate concentration in the intranuclear microenvironment of the cell&#xa0;is regulated; (3) The specific mechanisms through which histone lactylation regulates the &#x201c;lactate clock&#x201d; and achieves the inflammatory damage/anti-inflammatory repair balance; (4) Whether histone lactylation can completely repolarize M1 macrophages into M2 macrophages remains questionable; (5) The types of genes regulated by histone lactylation and the mechanisms governing its gene specificity. However, given the prevalence of lactylation in organisms and its involvement in diverse pathophysiological processes, both basic research and clinical translation on lactylation regulating macrophage metabolic reprogramming offer promising directions for further exploration.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>BX: Conceptualization, Methodology, Writing &#x2013; original draft. YL: Methodology, Writing &#x2013; original draft. NL: Funding acquisition, Supervision, Writing &#x2013; review &amp; editing. QG: Funding acquisition, Supervision, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants from the National Natural Science Foundation of China (No. 82102269).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>Figures are created with BioRender (<ext-link ext-link-type="uri" xlink:href="https://biorender.com/">https://biorender.com/</ext-link>).</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors&#xa0;and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>L</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage polarization and its role in liver disease</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>803037</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.803037</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shapouri-Moghaddam</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mohammadian</surname> <given-names>S</given-names>
</name>
<name>
<surname>Vazini</surname> <given-names>H</given-names>
</name>
<name>
<surname>Taghadosi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Esmaeili</surname> <given-names>S-A</given-names>
</name>
<name>
<surname>Mardani</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage plasticity, polarization, and function in health and disease</article-title>. <source>J Cell Physiol</source>. (<year>2018</year>) <volume>233</volume>:<page-range>6425&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcp.26429</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zen</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Molecular mechanisms that influence the macrophage m1-m2 polarization balance</article-title>. <source>Front Immunol</source>. (<year>2014</year>) <volume>5</volume>:<elocation-id>614</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2014.00614</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Biswas</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Fisher</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Gilroy</surname> <given-names>DW</given-names>
</name>
<name>
<surname>Goerdt</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage activation and polarization: nomenclature and experimental guidelines</article-title>. <source>Immunity</source>. (<year>2014</year>) <volume>41</volume>:<fpage>14</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.008</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>He</surname> <given-names>C</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>miR-142&#x2013;5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program</article-title>. <source>Nat Commun</source>. (<year>2015</year>) <volume>6</volume>:<fpage>8523</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms9523</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Dou</surname> <given-names>Y-N</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Q-W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J-Z</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Paeoniflorin suppresses TGF-&#x3b2; mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway</article-title>. <source>Acta Pharmacol Sin</source>. (<year>2016</year>) <volume>37</volume>:<fpage>794</fpage>&#x2013;<lpage>804</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/aps.2016.36</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wynn</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Chawla</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pollard</surname> <given-names>JW</given-names>
</name>
</person-group>. <article-title>Macrophage biology in development, homeostasis and disease</article-title>. <source>Nature</source>. (<year>2013</year>) <volume>496</volume>:<page-range>445&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature12034</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Viola</surname> <given-names>A</given-names>
</name>
<name>
<surname>Munari</surname> <given-names>F</given-names>
</name>
<name>
<surname>S&#xe1;nchez-Rodr&#xed;guez</surname> <given-names>R</given-names>
</name>
<name>
<surname>Scolaro</surname> <given-names>T</given-names>
</name>
<name>
<surname>Castegna</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>The metabolic signature of macrophage responses</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>1462</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.01462</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yunna</surname> <given-names>C</given-names>
</name>
<name>
<surname>Mengru</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>W</given-names>
</name>
<name>
<surname>Weidong</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Macrophage M1/M2 polarization</article-title>. <source>Eur J Pharmacol</source>. (<year>2020</year>) <volume>877</volume>:<elocation-id>173090</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2020.173090</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Sioud</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Tumor-associated macrophage subsets: shaping polarization and targeting</article-title>. <source>Int J Mol Sci</source>. (<year>2023</year>) <volume>24</volume>(<issue>8</issue>):<fpage>7493</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms24087493</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>C-Y</given-names>
</name>
<name>
<surname>Mauro</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Similarities in the metabolic reprogramming of immune system and endothelium</article-title>. <source>Front Immunol</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>837</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2017.00837</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>E</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Metabolic reprogramming in macrophage responses</article-title>. <source>biomark Res</source>. (<year>2021</year>) <volume>9</volume>:<elocation-id>1</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40364-020-00251-y</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El Kasmi</surname> <given-names>KC</given-names>
</name>
<name>
<surname>Stenmark</surname> <given-names>KR</given-names>
</name>
</person-group>. <article-title>Contribution of metabolic reprogramming to macrophage plasticity and function</article-title>. <source>Semin Immunol</source>. (<year>2015</year>) <volume>27</volume>:<page-range>267&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.smim.2015.09.001</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>B</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Han</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>M2-like tumor-associated macrophage-targeted codelivery of STAT6 inhibitor and IKK&#x3b2; siRNA induces M2-to-M1 repolarization for cancer immunotherapy with low immune side effects</article-title>. <source>ACS Cent Sci</source>. (<year>2020</year>) <volume>6</volume>:<page-range>1208&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acscentsci.9b01235</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>W</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Sequentially triggered bacterial outer membrane vesicles for macrophage metabolism modulation and tumor metastasis suppression</article-title>. <source>ACS Nano</source>. (<year>2021</year>) <volume>15</volume>:<page-range>13826&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acsnano.1c05613</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>P</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization</article-title>. <source>Biomaterials</source>. (<year>2021</year>) <volume>264</volume>:<elocation-id>120390</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biomaterials.2020.120390</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ling</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Ying</surname> <given-names>T</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>M1/M2 re-polarization of kaempferol biomimetic NPs in anti-inflammatory therapy of atherosclerosis</article-title>. <source>J Control Release</source>. (<year>2023</year>) <volume>353</volume>:<page-range>1068&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jconrel.2022.12.041</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van den Bossche</surname> <given-names>J</given-names>
</name>
<name>
<surname>Baardman</surname> <given-names>J</given-names>
</name>
<name>
<surname>Otto</surname> <given-names>NA</given-names>
</name>
<name>
<surname>van der Velden</surname> <given-names>S</given-names>
</name>
<name>
<surname>Neele</surname> <given-names>AE</given-names>
</name>
<name>
<surname>van den Berg</surname> <given-names>SM</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondrial dysfunction prevents repolarization of inflammatory macrophages</article-title>. <source>Cell Rep</source>. (<year>2016</year>) <volume>17</volume>:<page-range>684&#x2013;96</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2016.09.008</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vander Heiden</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Cantley</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>CB</given-names>
</name>
</person-group>. <article-title>Understanding the Warburg effect: the metabolic requirements of cell proliferation</article-title>. <source>Science</source>. (<year>2009</year>) <volume>324</volume>:<page-range>1029&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1160809</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ippolito</surname> <given-names>L</given-names>
</name>
<name>
<surname>Morandi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Giannoni</surname> <given-names>E</given-names>
</name>
<name>
<surname>Chiarugi</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Lactate: A metabolic driver in the tumour landscape</article-title>. <source>Trends Biochem Sci</source>. (<year>2019</year>) <volume>44</volume>:<page-range>153&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tibs.2018.10.011</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>G</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>C</given-names>
</name>
<name>
<surname>Weng</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Metabolic regulation of gene expression by histone lactylation</article-title>. <source>Nature</source>. (<year>2019</year>) <volume>574</volume>:<page-range>575&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586&#x2013;019-1678&#x2013;1</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>J-M</given-names>
</name>
<name>
<surname>Jo</surname> <given-names>S-H</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>M-Y</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>T-H</given-names>
</name>
<name>
<surname>Ahn</surname> <given-names>Y-H</given-names>
</name>
</person-group>. <article-title>Role of transcription factor acetylation in the regulation of metabolic homeostasis</article-title>. <source>Protein Cell</source>. (<year>2015</year>) <volume>6</volume>:<page-range>804&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s13238-015-0204-y</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Oncometabolites drive tumorigenesis by enhancing protein acylation: from chromosomal remodelling to nonhistone modification</article-title>. <source>J Exp Clin Cancer Res</source>. (<year>2022</year>) <volume>41</volume>:<fpage>144</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13046-022-02338-w</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tessarz</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kouzarides</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Histone core modifications regulating nucleosome structure and dynamics</article-title>. <source>Nat Rev Mol Cell Biol</source>. (<year>2014</year>) <volume>15</volume>:<page-range>703&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrm3890</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stillman</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Histone modifications: insights into their influence on gene expression</article-title>. <source>Cell</source>. (<year>2018</year>) <volume>175</volume>:<fpage>6</fpage>&#x2013;<lpage>9</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2018.08.032</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno-Yruela</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>W</given-names>
</name>
<name>
<surname>B&#xe6;k</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Class I histone deacetylases (HDAC1&#x2013;3) are histone lysine delactylases</article-title>. <source>Sci Adv</source>. (<year>2022</year>) <volume>8</volume>:<elocation-id>eabi6696</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciadv.abi6696</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sousa Silva</surname> <given-names>M</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Ferreira</surname> <given-names>AEN</given-names>
</name>
<name>
<surname>Ponces Freire</surname> <given-names>A</given-names>
</name>
<name>
<surname>Cordeiro</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>The glyoxalase pathway: the first hundred years &#x2026; and beyond</article-title>. <source>Biochem J</source>. (<year>2013</year>) <volume>453</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>15</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BJ20121743</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaffney</surname> <given-names>DO</given-names>
</name>
<name>
<surname>Jennings</surname> <given-names>EQ</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Marentette</surname> <given-names>JO</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Schou Oxvig</surname> <given-names>A-M</given-names>
</name>
<etal/>
</person-group>. <article-title>Non-enzymatic lysine lactoylation of glycolytic enzymes</article-title>. <source>Cell Chem Biol</source>. (<year>2020</year>) <volume>27</volume>(<issue>2</issue>):<page-range>206&#x2013;13.e6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chembiol.2019.11.005</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma</article-title>. <source>Sci Adv</source>. (<year>2023</year>) <volume>9</volume>:<elocation-id>eadg2697</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciadv.adg2697</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Hettinga</surname> <given-names>K</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Dietary d-lactate intake facilitates inflammatory resolution by modulating M1 macrophage polarization</article-title>. <source>Mol Nutr Food Res</source>. (<year>2022</year>) <volume>66</volume>:<elocation-id>e2200196</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/mnfr.202200196</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdel-Wahab</surname> <given-names>AF</given-names>
</name>
<name>
<surname>Mahmoud</surname> <given-names>W</given-names>
</name>
<name>
<surname>Al-Harizy</surname> <given-names>RM</given-names>
</name>
</person-group>. <article-title>Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy</article-title>. <source>Pharmacol Res</source>. (<year>2019</year>) <volume>150</volume>:<elocation-id>104511</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.phrs.2019.104511</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Islam</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Metabolic reprogramming of macrophages and its involvement in inflammatory diseases</article-title>. <source>EXCLI J</source>. (<year>2021</year>) <volume>20</volume>:<page-range>628&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.17179/excli2020&#x2013;3053</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van den Bossche</surname> <given-names>J</given-names>
</name>
<name>
<surname>Baardman</surname> <given-names>J</given-names>
</name>
<name>
<surname>de Winther</surname> <given-names>MPJ</given-names>
</name>
</person-group>. <article-title>Metabolic characterization of polarized M1 and M2 bone marrow-derived macrophages using real-time extracellular flux analysis</article-title>. <source>J Vis Exp</source>. (<year>2015</year>) <volume>105</volume>:<fpage>53424</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3791/53424</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramond</surname> <given-names>E</given-names>
</name>
<name>
<surname>Jamet</surname> <given-names>A</given-names>
</name>
<name>
<surname>Coureuil</surname> <given-names>M</given-names>
</name>
<name>
<surname>Charbit</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Pivotal role of mitochondria in macrophage response to bacterial pathogens</article-title>. <source>Front Immunol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>2461</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.02461</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>L</given-names>
</name>
<name>
<surname>He</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Regulations of glycolytic activities on macrophages functions in tumor and infectious inflammation</article-title>. <source>Front Cell Infect Microbiol</source>. (<year>2020</year>) <volume>10</volume>:<elocation-id>287</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.00287</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname> <given-names>W-J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>H-H</given-names>
</name>
<name>
<surname>Guan</surname> <given-names>X-X</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>J-B</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>C-C</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C-Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibition of glycolysis alleviates lipopolysaccharide-induced acute lung injury in a mouse model</article-title>. <source>J Cell Physiol</source>. (<year>2019</year>) <volume>234</volume>:<page-range>4641&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcp.27261</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>D</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Paraquat promotes acute lung injury in rats by regulating alveolar macrophage polarization through glycolysis</article-title>. <source>Ecotoxicol Environ Saf</source>. (<year>2021</year>) <volume>223</volume>:<elocation-id>112571</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ecoenv.2021.112571</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corcoran</surname> <given-names>SE</given-names>
</name>
<name>
<surname>O&#x2019;Neill</surname> <given-names>LAJ</given-names>
</name>
</person-group>. <article-title>HIF1&#x3b1; and metabolic reprogramming in inflammation</article-title>. <source>J Clin Invest</source>. (<year>2016</year>) <volume>126</volume>:<page-range>3699&#x2013;707</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI84431</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Codo</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Davanzo</surname> <given-names>GG</given-names>
</name>
<name>
<surname>Monteiro</surname> <given-names>L</given-names>
</name>
<name>
<surname>de Souza</surname> <given-names>GF</given-names>
</name>
<name>
<surname>Muraro</surname> <given-names>SP</given-names>
</name>
<name>
<surname>Virgilio-da-Silva</surname> <given-names>JV</given-names>
</name>
<etal/>
</person-group>. <article-title>Glucose levels favor SARS-coV-2 infection and monocyte response through a HIF-1&#x3b1;/glycolysis-dependent axis</article-title>. <source>Cell Metab</source>. (<year>2020</year>) <volume>32</volume>(<issue>3</issue>):<page-range>498&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2020.07.007</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palsson-McDermott</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Curtis</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Goel</surname> <given-names>G</given-names>
</name>
<name>
<surname>Lauterbach</surname> <given-names>MAR</given-names>
</name>
<name>
<surname>Sheedy</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Gleeson</surname> <given-names>LE</given-names>
</name>
<etal/>
</person-group>. <article-title>Pyruvate kinase M2 regulates Hif-1&#x3b1; activity and IL-1&#x3b2; induction and is a critical determinant of the warburg effect in LPS-activated macrophages</article-title>. <source>Cell Metab</source>. (<year>2015</year>) <volume>21</volume>:<fpage>65</fpage>&#x2013;<lpage>80</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2014.12.005</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>W</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>J</given-names>
</name>
<name>
<surname>Knabel</surname> <given-names>M</given-names>
</name>
<name>
<surname>O&#x2019;Meally</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1</article-title>. <source>Cell</source>. (<year>2011</year>) <volume>145</volume>:<page-range>732&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2011.03.054</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>T-Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J-Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J-Z</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect</article-title>. <source>Mil Med Res</source>. (<year>2022</year>) <volume>9</volume>:<elocation-id>22</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s40779&#x2013;022-00381&#x2013;4</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiese</surname> <given-names>EK</given-names>
</name>
<name>
<surname>Hitosugi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Loa</surname> <given-names>ST</given-names>
</name>
<name>
<surname>Sreedhar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Andres-Beck</surname> <given-names>LG</given-names>
</name>
<name>
<surname>Kurmi</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Enzymatic activation of pyruvate kinase increases cytosolic oxaloacetate to inhibit the Warburg effect</article-title>. <source>Nat Metab</source>. (<year>2021</year>) <volume>3</volume>:<page-range>954&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s42255&#x2013;021-00424&#x2013;5</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iniesta</surname> <given-names>V</given-names>
</name>
<name>
<surname>G&#xf3;mez-Nieto</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Corraliza</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages</article-title>. <source>J Exp Med</source>. (<year>2001</year>) <volume>193</volume>:<page-range>777&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1084/jem.193.6.777</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>G</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis</article-title>. <source>Cell Mol Immunol</source>. (<year>2022</year>) <volume>19</volume>:<page-range>504&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41423&#x2013;021-00806&#x2013;5</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname> <given-names>T</given-names>
</name>
<name>
<surname>Du</surname> <given-names>P</given-names>
</name>
<name>
<surname>Suo</surname> <given-names>L</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Song</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>High iodine promotes autoimmune thyroid disease by activating hexokinase 3 and inducing polarization of macrophages towards M1</article-title>. <source>Front Immunol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>1009932</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.1009932</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kotowski</surname> <given-names>K</given-names>
</name>
<name>
<surname>Rosik</surname> <given-names>J</given-names>
</name>
<name>
<surname>Machaj</surname> <given-names>F</given-names>
</name>
<name>
<surname>Supplitt</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wiczew</surname> <given-names>D</given-names>
</name>
<name>
<surname>Jab&#x142;o&#x144;ska</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of PFKFB3 and PFKFB4 in cancer: genetic basis, impact on disease development/progression, and potential as therapeutic targets</article-title>. <source>Cancers (Basel)</source>. (<year>2021</year>) <volume>13</volume>(<issue>4</issue>):<fpage>909</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cancers13040909</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schilperoort</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ngai</surname> <given-names>D</given-names>
</name>
<name>
<surname>Katerelos</surname> <given-names>M</given-names>
</name>
<name>
<surname>Power</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Tabas</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>PFKFB2-mediated glycolysis promotes lactate-driven continual efferocytosis by macrophages</article-title>. <source>Nat Metab</source>. (<year>2023</year>) <volume>5</volume>:<page-range>431&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s42255&#x2013;023-00736&#x2013;8</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mager</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Mormol</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Shelton</surname> <given-names>ED</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>PR</given-names>
</name>
<name>
<surname>Bowman</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Barley</surname> <given-names>TJ</given-names>
</name>
<etal/>
</person-group>. <article-title>p38 MAPK and MKP-1 control the glycolytic program via the bifunctional glycolysis regulator PFKFB3 during sepsis</article-title>. <source>J Biol Chem</source>. (<year>2023</year>) <volume>299</volume>:<elocation-id>103043</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jbc.2023.103043</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forteza</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Berg</surname> <given-names>M</given-names>
</name>
<name>
<surname>Edsfeldt</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J</given-names>
</name>
<name>
<surname>Baumgartner</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kareinen</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>Pyruvate dehydrogenase kinase regulates vascular inflammation in atherosclerosis and increases cardiovascular risk</article-title>. <source>Cardiovasc Res</source>. (<year>2023</year>) <volume>119</volume>:<page-range>1524&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cvr/cvad038</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Semba</surname> <given-names>H</given-names>
</name>
<name>
<surname>Takeda</surname> <given-names>N</given-names>
</name>
<name>
<surname>Isagawa</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sugiura</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Honda</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wake</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>HIF-1&#x3b1;-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity</article-title>. <source>Nat Commun</source>. (<year>2016</year>) <volume>7</volume>:<elocation-id>11635</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms11635</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Prados</surname> <given-names>J-C</given-names>
</name>
<name>
<surname>Trav&#xe9;s</surname> <given-names>PG</given-names>
</name>
<name>
<surname>Cuenca</surname> <given-names>J</given-names>
</name>
<name>
<surname>Rico</surname> <given-names>D</given-names>
</name>
<name>
<surname>Aragon&#xe9;s</surname> <given-names>J</given-names>
</name>
<name>
<surname>Mart&#xed;n-Sanz</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation</article-title>. <source>J Immunol</source>. (<year>2010</year>) <volume>185</volume>:<page-range>605&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.0901698</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>N</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>H</given-names>
</name>
<name>
<surname>Moellering</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Abraham</surname> <given-names>E</given-names>
</name>
<name>
<surname>Thannickal</surname> <given-names>VJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Pyruvate dehydrogenase kinase 1 participates in macrophage polarization via regulating glucose metabolism</article-title>. <source>J Immunol</source>. (<year>2015</year>) <volume>194</volume>:<page-range>6082&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1402469</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Covarrubias</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Aksoylar</surname> <given-names>HI</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Snyder</surname> <given-names>NW</given-names>
</name>
<name>
<surname>Worth</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Iyer</surname> <given-names>SS</given-names>
</name>
<etal/>
</person-group>. <article-title>Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation</article-title>. <source>Elife</source>. (<year>2016</year>) <volume>5</volume>:<elocation-id>e11612</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.11612</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robey</surname> <given-names>RB</given-names>
</name>
<name>
<surname>Hay</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Is Akt the &#x201c;Warburg kinase&#x201d;?-Akt-energy metabolism interactions and oncogenesis</article-title>. <source>Semin Cancer Biol</source>. (<year>2009</year>) <volume>19</volume>:<fpage>25</fpage>&#x2013;<lpage>31</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.semcancer.2008.11.010</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>SC-C</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Everts</surname> <given-names>B</given-names>
</name>
<name>
<surname>Colonna</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pearce</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Schilling</surname> <given-names>JD</given-names>
</name>
<etal/>
</person-group>. <article-title>Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation</article-title>. <source>Immunity</source>. (<year>2016</year>) <volume>45</volume>:<page-range>817&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2016.09.016</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Vuckovic</surname> <given-names>I</given-names>
</name>
<name>
<surname>Jeon</surname> <given-names>R</given-names>
</name>
<name>
<surname>Lerman</surname> <given-names>A</given-names>
</name>
<name>
<surname>Folmes</surname> <given-names>CD</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycolytic stimulation is not a requirement for M2 macrophage differentiation</article-title>. <source>Cell Metab</source>. (<year>2018</year>) <volume>28</volume>(<issue>3</issue>):<page-range>463&#x2013;75.e4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2018.08.012</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rath</surname> <given-names>M</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname> <given-names>I</given-names>
</name>
<name>
<surname>Kropf</surname> <given-names>P</given-names>
</name>
<name>
<surname>Closs</surname> <given-names>EI</given-names>
</name>
<name>
<surname>Munder</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages</article-title>. <source>Front Immunol</source>. (<year>2014</year>) <volume>5</volume>:<elocation-id>532</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2014.00532</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacMicking</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>QW</given-names>
</name>
<name>
<surname>Nathan</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Nitric oxide and macrophage function</article-title>. <source>Annu Rev Immunol</source>. (<year>1997</year>) <volume>15</volume>:<page-range>323&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.immunol.15.1.323</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mart&#xed; I L&#xed;ndez</surname> <given-names>A-A</given-names>
</name>
<name>
<surname>Reith</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Arginine-dependent immune responses</article-title>. <source>Cell Mol Life Sci</source>. (<year>2021</year>) <volume>78</volume>:<page-range>5303&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018&#x2013;021-03828&#x2013;4</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmieri</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Gonzalez-Cotto</surname> <given-names>M</given-names>
</name>
<name>
<surname>Baseler</surname> <given-names>WA</given-names>
</name>
<name>
<surname>Davies</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Ghesqui&#xe8;re</surname> <given-names>B</given-names>
</name>
<name>
<surname>Maio</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase</article-title>. <source>Nat Commun</source>. (<year>2020</year>) <volume>11</volume>:<fpage>698</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467&#x2013;020-14433&#x2013;7</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newsholme</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection</article-title>? <source>J Nutr</source>. (<year>2001</year>) <volume>131</volume>(<supplement>9 Suppl</supplement>):<page-range>2515S&#x2013;4S</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jn/131.9.2515S</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Connelly</surname> <given-names>L</given-names>
</name>
<name>
<surname>Palacios-Callender</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ameixa</surname> <given-names>C</given-names>
</name>
<name>
<surname>Moncada</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hobbs</surname> <given-names>AJ</given-names>
</name>
</person-group>. <article-title>Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide</article-title>. <source>J Immunol</source>. (<year>2001</year>) <volume>166</volume>:<page-range>3873&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.166.6.3873</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barron</surname> <given-names>L</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>AM</given-names>
</name>
<name>
<surname>El Kasmi</surname> <given-names>KC</given-names>
</name>
<name>
<surname>Qualls</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Cheever</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of arginase 1 from myeloid cells in th2-dominated lung inflammation</article-title>. <source>PloS One</source>. (<year>2013</year>) <volume>8</volume>:<elocation-id>e61961</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0061961</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El Kasmi</surname> <given-names>KC</given-names>
</name>
<name>
<surname>Qualls</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Pesce</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>RW</given-names>
</name>
<name>
<surname>Henao-Tamayo</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens</article-title>. <source>Nat Immunol</source>. (<year>2008</year>) <volume>9</volume>:<page-range>1399&#x2013;406</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ni.1671</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname> <given-names>P</given-names>
</name>
<name>
<surname>Lahiri</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lahiri</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chakravortty</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator</article-title>. <source>PloS Pathog</source>. (<year>2010</year>) <volume>6</volume>:<elocation-id>e1000899</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1000899</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monin</surname> <given-names>L</given-names>
</name>
<name>
<surname>Griffiths</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Lam</surname> <given-names>WY</given-names>
</name>
<name>
<surname>Gopal</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>DD</given-names>
</name>
<name>
<surname>Ahmed</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis</article-title>. <source>J Clin Invest</source>. (<year>2015</year>) <volume>125</volume>:<page-range>4699&#x2013;713</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI77378</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liberti</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Locasale</surname> <given-names>JW</given-names>
</name>
</person-group>. <article-title>The warburg effect: how does it benefit cancer cells</article-title>? <source>Trends Biochem Sci</source>. (<year>2016</year>) <volume>41</volume>:<page-range>211&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tibs.2015.12.001</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>A-N</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y-H</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>J-T</given-names>
</name>
<name>
<surname>Geng</surname> <given-names>X-M</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>J-P</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactylation, a novel metabolic reprogramming code: current status and prospects</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>688910</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.688910</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brooks</surname> <given-names>GA</given-names>
</name>
</person-group>. <article-title>Cell-cell and intracellular lactate shuttles</article-title>. <source>J Physiol</source>. (<year>2009</year>) <volume>587</volume>:<page-range>5591&#x2013;600</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1113/jphysiol.2009.178350</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brooks</surname> <given-names>GA</given-names>
</name>
</person-group>. <article-title>Lactate as a fulcrum of metabolism</article-title>. <source>Redox Biol</source>. (<year>2020</year>) <volume>35</volume>:<elocation-id>101454</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.redox.2020.101454</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Qian</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>Lactic acid: no longer an inert and end-product of glycolysis</article-title>. <source>Physiol (Bethesda)</source>. (<year>2017</year>) <volume>32</volume>:<page-range>453&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/physiol.00016.2017</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname> <given-names>L</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Crosstalk between glucose metabolism, lactate production and immune response modulation</article-title>. <source>Cytokine Growth Factor Rev</source>. (<year>2022</year>) <volume>68</volume>:<fpage>81</fpage>&#x2013;<lpage>92</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cytogfr.2022.11.001</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tasdogan</surname> <given-names>A</given-names>
</name>
<name>
<surname>Faubert</surname> <given-names>B</given-names>
</name>
<name>
<surname>Ramesh</surname> <given-names>V</given-names>
</name>
<name>
<surname>Ubellacker</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>B</given-names>
</name>
<name>
<surname>Solmonson</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Metabolic heterogeneity confers differences in melanoma metastatic potential</article-title>. <source>Nature</source>. (<year>2020</year>) <volume>577</volume>:<page-range>115&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41586&#x2013;019-1847&#x2013;2</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivashkiv</surname> <given-names>LB</given-names>
</name>
</person-group>. <article-title>The hypoxia-lactate axis tempers inflammation</article-title>. <source>Nat Rev Immunol</source>. (<year>2020</year>) <volume>20</volume>:<page-range>85&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41577&#x2013;019-0259&#x2013;8</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kes</surname> <given-names>MMG</given-names>
</name>
<name>
<surname>Van den Bossche</surname> <given-names>J</given-names>
</name>
<name>
<surname>Griffioen</surname> <given-names>AW</given-names>
</name>
<name>
<surname>Huijbers</surname> <given-names>EJM</given-names>
</name>
</person-group>. <article-title>Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors</article-title>. <source>Biochim Biophys Acta Rev Cancer</source>. (<year>2020</year>) <volume>1874</volume>:<elocation-id>188427</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbcan.2020.188427</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colegio</surname> <given-names>OR</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>N-Q</given-names>
</name>
<name>
<surname>Szabo</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Rhebergen</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Jairam</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Functional polarization of tumour-associated macrophages by tumour-derived lactic acid</article-title>. <source>Nature</source>. (<year>2014</year>) <volume>513</volume>:<page-range>559&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature13490</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Dalgard</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Mohyeldin</surname> <given-names>A</given-names>
</name>
<name>
<surname>McFate</surname> <given-names>T</given-names>
</name>
<name>
<surname>Tait</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Verma</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1</article-title>. <source>J Biol Chem</source>. (<year>2005</year>) <volume>280</volume>:<page-range>41928&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M508718200</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mead</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Hughes</surname> <given-names>TR</given-names>
</name>
<name>
<surname>Irvine</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>NN</given-names>
</name>
<name>
<surname>Ramji</surname> <given-names>DP</given-names>
</name>
</person-group>. <article-title>Interferon-gamma stimulates the expression of the inducible cAMP early repressor in macrophages through the activation of casein kinase 2. A potentially novel pathway for interferon-gamma-mediated inhibition of gene transcription</article-title>. <source>J Biol Chem</source>. (<year>2003</year>) <volume>278</volume>:<page-range>17741&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M301602200</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolick</surname> <given-names>DT</given-names>
</name>
<name>
<surname>Skaflen</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>S-C</given-names>
</name>
<name>
<surname>Howatt</surname> <given-names>D</given-names>
</name>
<name>
<surname>Daugherty</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>G2A deficiency in mice promotes macrophage activation and atherosclerosis</article-title>. <source>Circ Res</source>. (<year>2009</year>) <volume>104</volume>:<page-range>318&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.181131</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Justus</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>LV</given-names>
</name>
</person-group>. <article-title>Acidic tumor microenvironment and pH-sensing G protein-coupled receptors</article-title>. <source>Front Physiol</source>. (<year>2013</year>) <volume>4</volume>:<elocation-id>354</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphys.2013.00354</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>P</given-names>
</name>
<name>
<surname>Zuo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kolar</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Chu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Saghatelian</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2017</year>) <volume>114</volume>:<page-range>580&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1614035114</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bohn</surname> <given-names>T</given-names>
</name>
<name>
<surname>Rapp</surname> <given-names>S</given-names>
</name>
<name>
<surname>Luther</surname> <given-names>N</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bruehl</surname> <given-names>T-J</given-names>
</name>
<name>
<surname>Kojima</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages</article-title>. <source>Nat Immunol</source>. (<year>2018</year>) <volume>19</volume>:<page-range>1319&#x2013;29</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590&#x2013;018-0226&#x2013;8</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kuang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2&#x3b1;-mediated tumor progression</article-title>. <source>J Clin Invest</source>. (<year>2019</year>) <volume>129</volume>:<page-range>631&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI123027</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>A</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>J</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ni</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17</article-title>. <source>Theranostics</source>. (<year>2021</year>) <volume>11</volume>:<page-range>3839&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/thno.53749</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>T</given-names>
</name>
<name>
<surname>Geng</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer</article-title>. <source>Cell Cycle</source>. (<year>2018</year>) <volume>17</volume>:<page-range>428&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/15384101.2018.1444305</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kuei</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shelton</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81</article-title>. <source>J Biol Chem</source>. (<year>2009</year>) <volume>284</volume>:<page-range>2811&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M806409200</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname> <given-names>TP</given-names>
</name>
<name>
<surname>Ganapathy</surname> <given-names>V</given-names>
</name>
</person-group>. <article-title>Lactate/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon</article-title>. <source>Pharmacol Ther</source>. (<year>2020</year>) <volume>206</volume>:<elocation-id>107451</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pharmthera.2019.107451</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morrissey</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>C</given-names>
</name>
<name>
<surname>Montoya-Durango</surname> <given-names>DE</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming</article-title>. <source>Cell Metab</source>. (<year>2021</year>) <volume>33</volume>(<issue>10</issue>):<page-range>2040&#x2013;58.e10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2021.09.002</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lokhande</surname> <given-names>K</given-names>
</name>
<name>
<surname>Joshi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Khunteta</surname> <given-names>K</given-names>
</name>
<name>
<surname>Pal</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Predicted Role of Acetyl-CoA Synthetase and HAT p300 in Extracellular Lactate Mediated Lactylation in the Tumor: In vitro and In silico Models</article-title>. <source>Curr Chem Biol</source>. (<year>2023</year>) <volume>18</volume>(<issue>4</issue>). doi:&#xa0;<pub-id pub-id-type="doi">10.2174/0122127968256108231226074336</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varner</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Trefely</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bartee</surname> <given-names>D</given-names>
</name>
<name>
<surname>von Krusenstiern</surname> <given-names>E</given-names>
</name>
<name>
<surname>Izzo</surname> <given-names>L</given-names>
</name>
<name>
<surname>Bekeova</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Quantification of lactoyl-CoA (lactyl-CoA) by liquid chromatography mass spectrometry in mammalian cells and tissues</article-title>. <source>Open Biol</source>. (<year>2020</year>) <volume>10</volume>:<elocation-id>200187</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1098/rsob.200187</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liberti</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Locasale</surname> <given-names>JW</given-names>
</name>
</person-group>. <article-title>Histone lactylation: A new role for glucose metabolism</article-title>. <source>Trends Biochem Sci</source>. (<year>2020</year>) <volume>45</volume>:<page-range>179&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tibs.2019.12.004</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irizarry-Caro</surname> <given-names>RA</given-names>
</name>
<name>
<surname>McDaniel</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Overcast</surname> <given-names>GR</given-names>
</name>
<name>
<surname>Jain</surname> <given-names>VG</given-names>
</name>
<name>
<surname>Troutman</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Pasare</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>TLR signaling adapter BCAP regulates inflammatory to reparatory macrophage transition by promoting histone lactylation</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2020</year>) <volume>117</volume>:<page-range>30628&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.2009778117</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>N</given-names>
</name>
<name>
<surname>Banerjee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Dey</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Lung myofibroblasts promote macrophage profibrotic activity through lactate-induced histone lactylation</article-title>. <source>Am J Respir Cell Mol Biol</source>. (<year>2021</year>) <volume>64</volume>:<page-range>115&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1165/rcmb.2020-0360OC</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Mang</surname> <given-names>G</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Histone lactylation boosts reparative gene activation post-myocardial infarction</article-title>. <source>Circ Res</source>. (<year>2022</year>) <volume>131</volume>:<fpage>893</fpage>&#x2013;<lpage>908</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.122.320488</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noe</surname> <given-names>JT</given-names>
</name>
<name>
<surname>Rendon</surname> <given-names>BE</given-names>
</name>
<name>
<surname>Geller</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Conroy</surname> <given-names>LR</given-names>
</name>
<name>
<surname>Morrissey</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Young</surname> <given-names>LEA</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactate supports a metabolic-epigenetic link in macrophage polarization</article-title>. <source>Sci Adv</source>. (<year>2021</year>) <volume>7</volume>:<elocation-id>eabi8602</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciadv.abi8602</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dichtl</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lindenthal</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zeitler</surname> <given-names>L</given-names>
</name>
<name>
<surname>Behnke</surname> <given-names>K</given-names>
</name>
<name>
<surname>Schl&#xf6;sser</surname> <given-names>D</given-names>
</name>
<name>
<surname>Strobl</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactate and IL6 define separable paths of inflammatory metabolic adaptation</article-title>. <source>Sci Adv</source>. (<year>2021</year>) <volume>7</volume>(<issue>26</issue>):<elocation-id>eabg3505</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciadv.abg3505</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Troutman</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Fulenchek</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yamazaki</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kurosaki</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bazan</surname> <given-names>JF</given-names>
</name>
<etal/>
</person-group>. <article-title>Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>2012</year>) <volume>109</volume>:<page-range>273&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.1118579109</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fitzgerald</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Kagan</surname> <given-names>JC</given-names>
</name>
</person-group>. <article-title>Toll-like receptors and the control of immunity</article-title>. <source>Cell</source>. (<year>2020</year>) <volume>180</volume>:<page-range>1044&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2020.02.041</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zanoni</surname> <given-names>I</given-names>
</name>
<name>
<surname>Ostuni</surname> <given-names>R</given-names>
</name>
<name>
<surname>Marek</surname> <given-names>LR</given-names>
</name>
<name>
<surname>Barresi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Barbalat</surname> <given-names>R</given-names>
</name>
<name>
<surname>Barton</surname> <given-names>GM</given-names>
</name>
<etal/>
</person-group>. <article-title>CD14 controls the LPS-induced endocytosis of Toll-like receptor 4</article-title>. <source>Cell</source>. (<year>2011</year>) <volume>147</volume>:<page-range>868&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2011.09.051</pub-id>
</citation>
</ref>
<ref id="B101">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactylation of PKM2 suppresses inflammatory metabolic adaptation in pro-inflammatory macrophages</article-title>. <source>Int J Biol Sci</source>. (<year>2022</year>) <volume>18</volume>:<page-range>6210&#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/ijbs.75434</pub-id>
</citation>
</ref>
<ref id="B102">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis</article-title>. <source>Cell Death Differ</source>. (<year>2022</year>) <volume>29</volume>:<page-range>133&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41418&#x2013;021-00841&#x2013;9</pub-id>
</citation>
</ref>
<ref id="B103">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Heinb&#xe4;ck</surname> <given-names>R</given-names>
</name>
<name>
<surname>Salo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ewing</surname> <given-names>E</given-names>
</name>
<name>
<surname>Espinosa</surname> <given-names>A</given-names>
</name>
<name>
<surname>Aulin</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Transcriptomic profiling reveals that HMGB1 induces macrophage polarization different from classical M1</article-title>. <source>Biomolecules</source>. (<year>2022</year>) <volume>12</volume>(<issue>6</issue>):<fpage>779</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biom12060779</pub-id>
</citation>
</ref>
<ref id="B104">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Hepatocyte HSPA12A inhibits macrophage chemotaxis and activation to attenuate liver ischemia/reperfusion injury via suppressing glycolysis-mediated HMGB1 lactylation and secretion of hepatocytes</article-title>. <source>Theranostics</source>. (<year>2023</year>) <volume>13</volume>:<page-range>3856&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/thno.82607</pub-id>
</citation>
</ref>
<ref id="B105">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeong</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Ahn</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Sohn</surname> <given-names>TK</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>MH</given-names>
</name>
<etal/>
</person-group>. <article-title>Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation</article-title>. <source>Cell</source>. (<year>2002</year>) <volume>111</volume>:<page-range>709&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0092-8674(02)01085-1</pub-id>
</citation>
</ref>
<ref id="B106">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xin</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactylation: a passing fad or the future of posttranslational modification</article-title>. <source>Inflammation</source>. (<year>2022</year>) <volume>45</volume>:<page-range>1419&#x2013;29</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10753-022-01637-w</pub-id>
</citation>
</ref>
<ref id="B107">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rius</surname> <given-names>J</given-names>
</name>
<name>
<surname>Guma</surname> <given-names>M</given-names>
</name>
<name>
<surname>Schachtrup</surname> <given-names>C</given-names>
</name>
<name>
<surname>Akassoglou</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zinkernagel</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Nizet</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha</article-title>. <source>Nature</source>. (<year>2008</year>) <volume>453</volume>:<page-range>807&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nature06905</pub-id>
</citation>
</ref>
<ref id="B108">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirchandani</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Jenkins</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Bain</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Sanchez-Garcia</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Lawson</surname> <given-names>H</given-names>
</name>
<name>
<surname>Coelho</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation</article-title>. <source>Nat Immunol</source>. (<year>2022</year>) <volume>23</volume>:<page-range>927&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590-022-01216-z</pub-id>
</citation>
</ref>
<ref id="B109">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Berg</surname> <given-names>NK</given-names>
</name>
<name>
<surname>Mills</surname> <given-names>T</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Eltzschig</surname> <given-names>HK</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Adenosine at the interphase of hypoxia and inflammation in lung injury</article-title>. <source>Front Immunol</source>. (<year>2020</year>) <volume>11</volume>:<elocation-id>604944</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.604944</pub-id>
</citation>
</ref>
<ref id="B110">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Susser</surname> <given-names>LI</given-names>
</name>
<name>
<surname>Nguyen</surname> <given-names>M-A</given-names>
</name>
<name>
<surname>Geoffrion</surname> <given-names>M</given-names>
</name>
<name>
<surname>Emerton</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ouimet</surname> <given-names>M</given-names>
</name>
<name>
<surname>Khacho</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondrial fragmentation promotes inflammation resolution responses in macrophages via histone lactylation</article-title>. <source>Mol Cell Biol</source>. (<year>2023</year>) <volume>43</volume>:<page-range>531&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10985549.2023.2253131</pub-id>
</citation>
</ref>
<ref id="B111">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ji</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Integrated metabolism and epigenetic modifications in the macrophages of mice in responses to cold stress</article-title>. <source>J Zhejiang Univ Sci B</source>. (<year>2022</year>) <volume>23</volume>:<page-range>461&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1631/jzus.B2101091</pub-id>
</citation>
</ref>
<ref id="B112">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname> <given-names>R-Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer&#x2019;s disease</article-title>. <source>Cell Metab</source>. (<year>2022</year>) <volume>34</volume>(<issue>4</issue>):<page-range>634&#x2013;48.e6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2022.02.013</pub-id>
</citation>
</ref>
<ref id="B113">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>XM</given-names>
</name>
<name>
<surname>Geng</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Law</surname> <given-names>BY-K</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>MCT4-dependent lactate transport: a novel mechanism for cardiac energy metabolism injury and inflammation in type 2 diabetes mellitus</article-title>. <source>Cardiovasc Diabetol</source>. (<year>2024</year>) <volume>23</volume>:<fpage>96</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12933&#x2013;024-02178&#x2013;2</pub-id>
</citation>
</ref>
<ref id="B114">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishore</surname> <given-names>A</given-names>
</name>
<name>
<surname>Petrek</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Roles of macrophage polarization and macrophage-derived miRNAs in pulmonary fibrosis</article-title>. <source>Front Immunol</source>. (<year>2021</year>) <volume>12</volume>:<elocation-id>678457</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.678457</pub-id>
</citation>
</ref>
<ref id="B115">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname> <given-names>N</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Banerjee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>J</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>R-M</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis</article-title>. <source>Am J Respir Crit Care Med</source>. (<year>2015</year>) <volume>192</volume>:<page-range>1462&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.201504-0780OC</pub-id>
</citation>
</ref>
<ref id="B116">
<label>116</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Summer</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Cellular metabolism in lung health and disease</article-title>. <source>Annu Rev Physiol</source>. (<year>2019</year>) <volume>81</volume>:<page-range>403&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-physiol-020518&#x2013;114640</pub-id>
</citation>
</ref>
<ref id="B117">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname> <given-names>SYC</given-names>
</name>
<name>
<surname>Collins</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Gout</surname> <given-names>PW</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite</article-title>? <source>J Pathol</source>. (<year>2013</year>) <volume>230</volume>:<page-range>350&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/path.4218</pub-id>
</citation>
</ref>
<ref id="B118">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>P</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Shan</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Lactate induces tumor-associated macrophage polarization independent of mitochondrial pyruvate carrier-mediated metabolism</article-title>. <source>Int J Biol Macromol</source>. (<year>2023</year>) <volume>237</volume>:<elocation-id>123810</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.123810</pub-id>
</citation>
</ref>
<ref id="B119">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages</article-title>. <source>J Exp Clin Cancer Res</source>. (<year>2022</year>) <volume>41</volume>:<fpage>303</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13046&#x2013;022-02477&#x2013;0</pub-id>
</citation>
</ref>
<ref id="B120">
<label>120</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>A</given-names>
</name>
<name>
<surname>Li</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer</article-title>. <source>Front Immunol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1149989</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1149989</pub-id>
</citation>
</ref>
<ref id="B121">
<label>121</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudagar</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hieromnimon</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Kelley</surname> <given-names>A</given-names>
</name>
<name>
<surname>Labadie</surname> <given-names>B</given-names>
</name>
<name>
<surname>Shafran</surname> <given-names>J</given-names>
</name>
<name>
<surname>Rameshbabu</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosis</article-title>. <source>Clin Cancer Res</source>. (<year>2023</year>) <volume>29</volume>:<page-range>4930&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/1078&#x2013;0432.CCR-23&#x2013;1441</pub-id>
</citation>
</ref>
<ref id="B122">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudagar</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hieromnimon</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Khurana</surname> <given-names>R</given-names>
</name>
<name>
<surname>Labadie</surname> <given-names>B</given-names>
</name>
<name>
<surname>Hirz</surname> <given-names>T</given-names>
</name>
<name>
<surname>Mei</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Reversal of lactate and PD-1-mediated macrophage immunosuppression controls growth of PTEN/p53-deficient prostate cancer</article-title>. <source>Clin Cancer Res</source>. (<year>2023</year>) <volume>29</volume>:<page-range>1952&#x2013;68</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/1078&#x2013;0432.CCR-22&#x2013;3350</pub-id>
</citation>
</ref>
<ref id="B123">
<label>123</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>P</given-names>
</name>
<name>
<surname>Xiang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Lactate-lactylation hands between metabolic reprogramming and immunosuppression</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>(<issue>19</issue>):<fpage>11943</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms231911943</pub-id>
</citation>
</ref>
</ref-list>
<glossary>
<title>Glossary</title>
<table-wrap position="anchor">
<table frame="hsides">
<tbody>
<tr>
<td>ACO2</td>
<td>aconitase 2</td>
</tr>
<tr>
<td>Arg1</td>
<td>arginase 1</td>
</tr>
<tr>
<td>BCAP</td>
<td>B-cell adapter for PI3K</td>
</tr>
<tr>
<td>BMDM</td>
<td>bone-marrow-derived macrophage</td>
</tr>
<tr>
<td>CBP</td>
<td>cAMP response element-binding protein (CREB) binding protein</td>
</tr>
<tr>
<td>DAMP</td>
<td>damage associated molecular pattern</td>
</tr>
<tr>
<td>EMT</td>
<td>epithelial-mesenchymal transition</td>
</tr>
<tr>
<td>ERK</td>
<td>extracellular signal-regulated kinase</td>
</tr>
<tr>
<td>ETC</td>
<td>electron transport chain</td>
</tr>
<tr>
<td>F-1,6-BP</td>
<td>fructose 1,6-bisphosphate</td>
</tr>
<tr>
<td>F-2,6-BP</td>
<td>fructose 2,6-bisphosphate</td>
</tr>
<tr>
<td>F-6-P</td>
<td>fructose 6-phosphate</td>
</tr>
<tr>
<td>FAS</td>
<td>fatty acid synthesis</td>
</tr>
<tr>
<td>FMT</td>
<td>fibroblast-to-myofibroblast transition</td>
</tr>
<tr>
<td>FOXO1</td>
<td>forkhead box protein O1</td>
</tr>
<tr>
<td>G-6-P</td>
<td>glucose 6-phosphate</td>
</tr>
<tr>
<td>GLO</td>
<td>glyoxalase</td>
</tr>
<tr>
<td>GLUT1</td>
<td>glucose transporter protein 1</td>
</tr>
<tr>
<td>GSK3&#x3b2;</td>
<td>glycogen synthase kinase 3&#x3b2;</td>
</tr>
<tr>
<td>HDAC</td>
<td>histone deacetylase</td>
</tr>
<tr>
<td>HIF-1&#x3b1;</td>
<td>hypoxia-inducible factor-1&#x3b1;</td>
</tr>
<tr>
<td>HK</td>
<td>hexokinase</td>
</tr>
<tr>
<td>HMGB1</td>
<td>high mobility group box 1</td>
</tr>
<tr>
<td>HRE</td>
<td>hypoxia-responsive element</td>
</tr>
<tr>
<td>HSPA12A</td>
<td>heat shock protein A12A</td>
</tr>
<tr>
<td>iNOS</td>
<td>inducible nitric oxide synthase</td>
</tr>
<tr>
<td>IRF3</td>
<td>interferon regulatory factor 3</td>
</tr>
<tr>
<td>JAK</td>
<td>janus kinase</td>
</tr>
<tr>
<td>LDHA</td>
<td>lactate dehydrogenase A</td>
</tr>
<tr>
<td>LGSH</td>
<td>lactoylglutathione</td>
</tr>
<tr>
<td>MCT</td>
<td>monocarboxylate transporter</td>
</tr>
<tr>
<td>MGO</td>
<td>methylglyoxal</td>
</tr>
<tr>
<td>MPC</td>
<td>mitochondrial pyruvate carrier</td>
</tr>
<tr>
<td>mTORC1</td>
<td>mammalian target of rapamycin complex 1</td>
</tr>
<tr>
<td>mTORC2</td>
<td>mammalian target of rapamycin complex 2</td>
</tr>
<tr>
<td>NF-&#x3ba;B</td>
<td>nuclear factor kappa-light-chain-enhancer of activated B cells</td>
</tr>
<tr>
<td>NO</td>
<td>nitric oxide</td>
</tr>
<tr>
<td>OAT</td>
<td>ornithine aminotransferase</td>
</tr>
<tr>
<td>ODC</td>
<td>ornithine decarboxylase</td>
</tr>
<tr>
<td>OXPHOS</td>
<td>oxidative phosphorylation</td>
</tr>
<tr>
<td>PCSK9</td>
<td>proprotein convertase subtilisin/kexin type 9</td>
</tr>
<tr>
<td>PDH</td>
<td>pyruvate dehydrogenase</td>
</tr>
<tr>
<td>PDK1</td>
<td>pyruvate dehydrogenase kinase 1</td>
</tr>
<tr>
<td>PD-L1</td>
<td>programmed death-ligand 1</td>
</tr>
<tr>
<td>PFK1</td>
<td>phosphofructokinase 1</td>
</tr>
<tr>
<td>PFKFB</td>
<td>fructose-6-phosphate-2-kinase/fructose-2,6-bisphosphatase</td>
</tr>
<tr>
<td>PI3K</td>
<td>phosphoinositide 3-kinase</td>
</tr>
<tr>
<td>PK</td>
<td>pyruvate kinase</td>
</tr>
<tr>
<td>PKM2</td>
<td>pyruvate kinase M2</td>
</tr>
<tr>
<td>PPP</td>
<td>pentose phosphate pathway</td>
</tr>
<tr>
<td>PRR</td>
<td>pattern recognition receptor</td>
</tr>
<tr>
<td>ROS</td>
<td>reactive oxygen species</td>
</tr>
<tr>
<td>STAT3</td>
<td>signal transducer and activator of transcription 3</td>
</tr>
<tr>
<td>STAT6</td>
<td>signal transducer and activator of transcription 6</td>
</tr>
<tr>
<td>TAM</td>
<td>tumor-associated macrophages</td>
</tr>
<tr>
<td>TCA cycle</td>
<td>tricarboxylic acid cycle</td>
</tr>
<tr>
<td>TDE</td>
<td>tumor - derived exosome</td>
</tr>
<tr>
<td>TFEB</td>
<td>transcription factor EB</td>
</tr>
<tr>
<td>TLR</td>
<td>toll-like receptor</td>
</tr>
<tr>
<td>TME</td>
<td>tumor microenvironment</td>
</tr>
<tr>
<td>VEGF</td>
<td>vascular endothelial growth factor</td>
</tr>
</tbody>
</table>
</table-wrap>
</glossary>
</back>
</article>
